1
|
Rathinam Thiruppathi Venkadajapathy V, Sivaperumal S. Tailoring functional two-dimensional nanohybrids: A comprehensive approach for enhancing photocatalytic remediation. ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY 2024; 275:116221. [PMID: 38547728 DOI: 10.1016/j.ecoenv.2024.116221] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/18/2023] [Revised: 02/07/2024] [Accepted: 03/14/2024] [Indexed: 04/12/2024]
Abstract
Photocatalysis is gaining prominence as a viable alternative to conventional biohazard treatment technologies. Two-dimensional (2D) nanomaterials have become crucial for fabricating novel photocatalysts due to their nanosheet architectures, large surface areas, and remarkable physicochemical properties. Furthermore, a variety of applications are possible with 2D nanomaterials, either in combination with other functional nanoparticles or by utilizing their inherent properties. Henceforth, the review commences its exploration into the synthesis of these materials, delving into their inherent properties and assessing their biocompatibility. Subsequently, an overview of mechanisms involved in the photocatalytic degradation of pollutants and the processes related to antimicrobial action is presented. As an integral part of our review, we conduct a systematic analysis of existing challenges and various types of 2D nanohybrid materials tailored for applications in the photocatalytic degradation of contaminants and the inactivation of pathogens through photocatalysis. This investigation will aid to contribute to the formulation of decision-making criteria and design principles for the next generation of 2D nanohybrid materials. Additionally, it is crucial to emphasize that further research is imperative for advancing our understanding of 2D nanohybrid materials.
Collapse
|
2
|
Yin Y, Ge X, Ouyang J, Na N. Tumor-activated in situ synthesis of single-atom catalysts for O 2-independent photodynamic therapy based on water-splitting. Nat Commun 2024; 15:2954. [PMID: 38582750 PMCID: PMC11258260 DOI: 10.1038/s41467-024-46987-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2023] [Accepted: 03/15/2024] [Indexed: 04/08/2024] Open
Abstract
Single-atom catalysts (SACs) have attracted interest in photodynamic therapy (PDT), while they are normally limited by the side effects on normal tissues and the interference from the Tumor Microenvironment (TME). Here we show a TME-activated in situ synthesis of SACs for efficient tumor-specific water-based PDT. Upon reduction by upregulated GSH in TME, C3N4-Mn SACs are obtained in TME with Mn atomically coordinated into the cavity of C3N4 nanosheets. This in situ synthesis overcomes toxicity from random distribution and catalyst release in healthy tissues. Based on the Ligand-to-Metal charge transfer (LMCT) process, C3N4-Mn SACs exhibit enhanced absorption in the red-light region. Thereby, a water-splitting process is induced by C3N4-Mn SACs under 660 nm irradiation, which initiates the O2-independent generation of highly toxic hydroxyl radical (·OH) for cancer-specific PDT. Subsequently, the ·OH-initiated lipid peroxidation process is demonstrated to devote effective cancer cell death. The in situ synthesized SACs facilitate the precise cancer-specific conversion of inert H2O to reactive ·OH, which facilitates efficient cancer therapy in female mice. This strategy achieves efficient and precise cancer therapy, not only avoiding the side effects on normal tissues but also overcoming tumor hypoxia.
Collapse
Affiliation(s)
- Yiyan Yin
- Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing, 100875, China
| | - Xiyang Ge
- Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing, 100875, China
| | - Jin Ouyang
- Department of Chemistry, College of Arts and Sciences, Beijing Normal University at Zhuhai, Zhuhai, 519087, China
| | - Na Na
- Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing, 100875, China.
| |
Collapse
|
3
|
Lin H, Buerki-Thurnherr T, Kaur J, Wick P, Pelin M, Tubaro A, Carniel FC, Tretiach M, Flahaut E, Iglesias D, Vázquez E, Cellot G, Ballerini L, Castagnola V, Benfenati F, Armirotti A, Sallustrau A, Taran F, Keck M, Bussy C, Vranic S, Kostarelos K, Connolly M, Navas JM, Mouchet F, Gauthier L, Baker J, Suarez-Merino B, Kanerva T, Prato M, Fadeel B, Bianco A. Environmental and Health Impacts of Graphene and Other Two-Dimensional Materials: A Graphene Flagship Perspective. ACS NANO 2024; 18:6038-6094. [PMID: 38350010 PMCID: PMC10906101 DOI: 10.1021/acsnano.3c09699] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/06/2023] [Revised: 01/18/2024] [Accepted: 01/22/2024] [Indexed: 02/15/2024]
Abstract
Two-dimensional (2D) materials have attracted tremendous interest ever since the isolation of atomically thin sheets of graphene in 2004 due to the specific and versatile properties of these materials. However, the increasing production and use of 2D materials necessitate a thorough evaluation of the potential impact on human health and the environment. Furthermore, harmonized test protocols are needed with which to assess the safety of 2D materials. The Graphene Flagship project (2013-2023), funded by the European Commission, addressed the identification of the possible hazard of graphene-based materials as well as emerging 2D materials including transition metal dichalcogenides, hexagonal boron nitride, and others. Additionally, so-called green chemistry approaches were explored to achieve the goal of a safe and sustainable production and use of this fascinating family of nanomaterials. The present review provides a compact survey of the findings and the lessons learned in the Graphene Flagship.
Collapse
Affiliation(s)
- Hazel Lin
- CNRS,
UPR3572, Immunology, Immunopathology and Therapeutic Chemistry, ISIS, University of Strasbourg, 67000 Strasbourg, France
| | - Tina Buerki-Thurnherr
- Empa,
Swiss Federal Laboratories for Materials Science and Technology, Laboratory for Particles-Biology Interactions, 9014 St. Gallen, Switzerland
| | - Jasreen Kaur
- Nanosafety
& Nanomedicine Laboratory, Institute
of Environmental Medicine, Karolinska Institutet, 177 77 Stockholm, Sweden
| | - Peter Wick
- Empa,
Swiss Federal Laboratories for Materials Science and Technology, Laboratory for Particles-Biology Interactions, 9014 St. Gallen, Switzerland
| | - Marco Pelin
- Department
of Life Sciences, University of Trieste, 34127 Trieste, Italy
| | - Aurelia Tubaro
- Department
of Life Sciences, University of Trieste, 34127 Trieste, Italy
| | | | - Mauro Tretiach
- Department
of Life Sciences, University of Trieste, 34127 Trieste, Italy
| | - Emmanuel Flahaut
- CIRIMAT,
Université de Toulouse, CNRS, INPT,
UPS, 31062 Toulouse CEDEX 9, France
| | - Daniel Iglesias
- Facultad
de Ciencias y Tecnologías Químicas, Universidad de Castilla-La Mancha (UCLM), 13071 Ciudad Real, Spain
- Instituto
Regional de Investigación Científica Aplicada (IRICA), Universidad de Castilla-La Mancha (UCLM), 13071 Ciudad Real, Spain
| | - Ester Vázquez
- Facultad
de Ciencias y Tecnologías Químicas, Universidad de Castilla-La Mancha (UCLM), 13071 Ciudad Real, Spain
- Instituto
Regional de Investigación Científica Aplicada (IRICA), Universidad de Castilla-La Mancha (UCLM), 13071 Ciudad Real, Spain
| | - Giada Cellot
- International
School for Advanced Studies (SISSA), 34136 Trieste, Italy
| | - Laura Ballerini
- International
School for Advanced Studies (SISSA), 34136 Trieste, Italy
| | - Valentina Castagnola
- Center
for
Synaptic Neuroscience and Technology, Istituto
Italiano di Tecnologia, 16132 Genova, Italy
- IRCCS
Ospedale Policlinico San Martino, 16132 Genova, Italy
| | - Fabio Benfenati
- Center
for
Synaptic Neuroscience and Technology, Istituto
Italiano di Tecnologia, 16132 Genova, Italy
- IRCCS
Ospedale Policlinico San Martino, 16132 Genova, Italy
| | - Andrea Armirotti
- Analytical
Chemistry Facility, Istituto Italiano di
Tecnologia, 16163 Genoa, Italy
| | - Antoine Sallustrau
- Département
Médicaments et Technologies pour la Santé (DMTS), Université Paris-Saclay, CEA, INRAE, SIMoS, Gif-sur-Yvette 91191, France
| | - Frédéric Taran
- Département
Médicaments et Technologies pour la Santé (DMTS), Université Paris-Saclay, CEA, INRAE, SIMoS, Gif-sur-Yvette 91191, France
| | - Mathilde Keck
- Département
Médicaments et Technologies pour la Santé (DMTS), Université Paris-Saclay, CEA, INRAE, SIMoS, Gif-sur-Yvette 91191, France
| | - Cyrill Bussy
- Nanomedicine
Lab, Faculty of Biology, Medicine and Health, University of Manchester,
Manchester Academic Health Science Centre, National Graphene Institute, Manchester M13 9PT, United
Kingdom
| | - Sandra Vranic
- Nanomedicine
Lab, Faculty of Biology, Medicine and Health, University of Manchester,
Manchester Academic Health Science Centre, National Graphene Institute, Manchester M13 9PT, United
Kingdom
| | - Kostas Kostarelos
- Nanomedicine
Lab, Faculty of Biology, Medicine and Health, University of Manchester,
Manchester Academic Health Science Centre, National Graphene Institute, Manchester M13 9PT, United
Kingdom
| | - Mona Connolly
- Instituto Nacional de Investigación y Tecnología
Agraria
y Alimentaria (INIA), CSIC, Carretera de la Coruña Km 7,5, E-28040 Madrid, Spain
| | - José Maria Navas
- Instituto Nacional de Investigación y Tecnología
Agraria
y Alimentaria (INIA), CSIC, Carretera de la Coruña Km 7,5, E-28040 Madrid, Spain
| | - Florence Mouchet
- Laboratoire
Ecologie Fonctionnelle et Environnement, Université de Toulouse, CNRS, INPT, UPS, 31000 Toulouse, France
| | - Laury Gauthier
- Laboratoire
Ecologie Fonctionnelle et Environnement, Université de Toulouse, CNRS, INPT, UPS, 31000 Toulouse, France
| | - James Baker
- TEMAS Solutions GmbH, 5212 Hausen, Switzerland
| | | | - Tomi Kanerva
- Finnish Institute of Occupational Health, 00250 Helsinki, Finland
| | - Maurizio Prato
- Center
for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), 20014 Donostia-San
Sebastián, Spain
- Ikerbasque, Basque Foundation for Science, 48013 Bilbao, Spain
- Department
of Chemical and Pharmaceutical Sciences, University of Trieste, 34127 Trieste, Italy
| | - Bengt Fadeel
- Nanosafety
& Nanomedicine Laboratory, Institute
of Environmental Medicine, Karolinska Institutet, 177 77 Stockholm, Sweden
| | - Alberto Bianco
- CNRS,
UPR3572, Immunology, Immunopathology and Therapeutic Chemistry, ISIS, University of Strasbourg, 67000 Strasbourg, France
| |
Collapse
|
4
|
Vakili B, Karami-Darehnaranji M, Mirzaei E, Hosseini F, Nezafat N. Graphene oxide as novel vaccine adjuvant. Int Immunopharmacol 2023; 125:111062. [PMID: 37866317 DOI: 10.1016/j.intimp.2023.111062] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2023] [Revised: 09/30/2023] [Accepted: 10/10/2023] [Indexed: 10/24/2023]
Abstract
To improve antigen immunogenicity and promote long-lasting immunity, vaccine formulations have been appropriately supplemented with adjuvants. Graphene has been found to enhance the presentation of antigens to CD8+ T cells, as well as stimulating innate immune responses and inflammatory factors. Its properties, such as large surface area, water stability, and high aspect ratio, make it a suitable candidate for delivering biological substances. Graphene-based nanomaterials have recently attracted significant attention as a new type of vaccine adjuvants due to their potential role in the activation of immune responses. Due to the limited functionality of some approved human adjuvants for use, the development of new all-purpose adjuvants is urgently required. Research on the immunological and biomedical use of graphene oxide (GO) indicates that these nanocarriers possess excellent physicochemical properties, acceptable biocompatibility, and a high capacity for drug loading. Graphene-based nanocarriers also could improve the function of some immune cells such as dendritic cells and macrophages through specific signaling pathways. However, GO injection can lead to significant oxidative stress and inflammation. Various surface functionalization protocols have been employed to reduce possible adverse effects of GO, such as aggregation of GO in biological liquids and induce cell death. Furthermore, these modifications enhance the properties of functionalized-GO's qualities, making it an excellent carrier and adjuvant. Shedding light on different physicochemical and structural properties of GO and its derivatives has led to their application in various therapeutic and drug delivery fields. In this review, we have endeavored to elaborate on different aspects of GO.
Collapse
Affiliation(s)
- Bahareh Vakili
- Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Mahboubeh Karami-Darehnaranji
- Department of Medical Nanotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Esmaeil Mirzaei
- Department of Medical Nanotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Farnaz Hosseini
- Department of Medical Nanotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Navid Nezafat
- Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; Computational Vaccine and Drug Design Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
| |
Collapse
|
5
|
Sallustrau A, Keck M, Barbe P, Georgin D, Fresneau N, Campidelli S, Pibaleau B, Pinault M, Mayne-L'Hermite M, Granotier-Beckers C, Schlegel M, González VJ, Vázquez E, Servent D, Taran F. One-year post-exposure assessment of 14C-few-layer graphene biodistribution in mice: single versus repeated intratracheal administration. NANOSCALE 2023; 15:17621-17632. [PMID: 37877415 DOI: 10.1039/d3nr03711h] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/26/2023]
Abstract
Research on graphene-based nanomaterials has experienced exponential growth in the last few decades, driven by their unique properties and their future potential impact on our everyday life. With the increasing production and commercialization of these materials, there is significant interest in understanding their fate in vivo. Herein, we investigated the distribution of 14C-few-layer graphene (14C-FLG) flakes (lat. dim. ∼ 500 nm) in mice over a period of one year. Furthermore, we compared the effects of repeated low-dose and acute high-dose exposure by tracheal administration. The results showed that most of the radioactivity was found in the lungs in both cases, with longer elimination times in the case of acute high-dose administration. In order to gain deeper insights into the distribution pattern, we conducted ex vivo investigations using μ-autoradiography on tissue sections, revealing the heterogeneous distribution of the material following administration. For the first time, μ-autoradiography was used to conduct a comprehensive investigation into the distribution and potential presence of FLG within lung cells isolated from the exposed lungs. The presence of radioactivity in lung cells strongly suggests internalization of the 14C-FLG particles. Overall these results show the long-term accumulation of the material in the lungs over one year, regardless of the administration protocol, and the higher biopersistence of FLG in the case of an acute exposure. These findings highlight the importance of the exposure scenario in the context of intratracheal administration, which is of interest in the evaluation of the potential health risks of graphene-based nanomaterials.
Collapse
Affiliation(s)
- Antoine Sallustrau
- Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SCBM, 91191 Gif-sur-Yvette, France.
| | - Mathilde Keck
- Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SIMos, 91191 Gif-sur-Yvette, France
| | - Peggy Barbe
- Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SIMos, 91191 Gif-sur-Yvette, France
| | - Dominique Georgin
- Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SCBM, 91191 Gif-sur-Yvette, France.
| | - Nathalie Fresneau
- Université Paris-Saclay, CEA, CNRS, NIMBE, LICSEN, 91191 Gif-sur-Yvette, France
- Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SCBM, 91191 Gif-sur-Yvette, France.
| | - Stephane Campidelli
- Université Paris-Saclay, CEA, CNRS, NIMBE, LICSEN, 91191 Gif-sur-Yvette, France
| | - Baptiste Pibaleau
- Université Paris-Saclay, CEA, CNRS, NIMBE, LEDNA, 91191 Gif-sur-Yvette, France
| | - Mathieu Pinault
- Université Paris-Saclay, CEA, CNRS, NIMBE, LEDNA, 91191 Gif-sur-Yvette, France
| | | | - Christine Granotier-Beckers
- Université Paris Cité, Inserm, CEA, Stabilité Génétique Cellules Souches et Radiations/iRCM, 92265 Fontenay-aux-Roses, France
- Université Paris-Saclay, Inserm, CEA, Stabilité Génétique Cellules Souches et Radiations/iRCM, 92265 Fontenay-aux-Roses, France
| | - Michel Schlegel
- Université Paris Saclay, CEA, Service de Recherche en Matériaux et Procédés Avancés, 91191 Gif-sur-Yvette, France
| | - Viviana Jehová González
- Instituto Regional de Investigación Científica Aplicada (IRICA), Universidad de Castilla-La Mancha, 13071Ciudad Real, Spain
| | - Ester Vázquez
- Instituto Regional de Investigación Científica Aplicada (IRICA), Universidad de Castilla-La Mancha, 13071Ciudad Real, Spain
| | - Denis Servent
- Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SIMos, 91191 Gif-sur-Yvette, France
| | - Frédéric Taran
- Université Paris Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SCBM, 91191 Gif-sur-Yvette, France.
| |
Collapse
|
6
|
Zhu M, Zhu L, You Y, Sun M, Jin F, Song Y, Zhang J, Xu X, Ji J, Du Y. Positive Chemotaxis of CREKA-Modified Ceria@Polydopamine Biomimetic Nanoswimmers for Enhanced Penetration and Chemo-photothermal Tumor Therapy. ACS NANO 2023; 17:17285-17298. [PMID: 37595091 DOI: 10.1021/acsnano.3c05232] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 08/20/2023]
Abstract
Tumor interstitial pressure represents the greatest barrier against drug diffusion into the depth of the tumor. Biometric nanomotors highlight the possibility of enhanced deep penetration and improve cellular uptake. However, control of their directionality remains difficult to achieve. Herein, we report cysteine-arginine-glutamic acid-lysine-alanine (CREKA)-modified ceria@polydopamine nanobowls as tumor microenvironment-fueled nanoscale motors for positive chemotaxis into the tumor depth or toward tumor cells. Upon laser irradiation, this nanoswimmer rapidly depletes the tumor microenvironment-specific hydrogen peroxide (H2O2) in the nanobowl, contributing to a self-generated gradient and subsequently propulsion (9.5 μm/s at 46 °C). Moreover, the asymmetrical modification of CREKA on nanobowls could automatically reconfigure the motion direction toward tumor depth or tumor cells in response to receptor-ligand interaction, leading to a deep penetration (70 μm in multicellular spheroids) and enhanced antitumor effects over conventional nanomedicine-induced chemo-photothermal therapy (tumor growth inhibition rate: 84.2% versus 56.9%). Thus, controlling the direction of nanomotors holds considerable potential for improved antitumor responses, especially in solid tumors with high tumor interstitial pressure.
Collapse
Affiliation(s)
- Minxia Zhu
- Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, P.R. China
| | - Luwen Zhu
- Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, P.R. China
| | - Yuchan You
- Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, P.R. China
| | - Mingchen Sun
- Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, P.R. China
| | - Feiyang Jin
- Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, P.R. China
| | - Yanling Song
- Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, P.R. China
| | - Jucong Zhang
- Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, P.R. China
| | - Xiaoling Xu
- Shulan International Medical College, Zhejiang Shuren University, Hangzhou 310015, China
| | - Jiansong Ji
- Department of Radiology, Lishui Hospital of Zhejiang University, Lishui 323000, China
| | - Yongzhong Du
- Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, P.R. China
| |
Collapse
|
7
|
Sabiu G, Kasinath V, Jung S, Li X, Tsokos GC, Abdi R. Targeted nanotherapy for kidney diseases: a comprehensive review. Nephrol Dial Transplant 2023; 38:1385-1396. [PMID: 35945647 PMCID: PMC10229287 DOI: 10.1093/ndt/gfac233] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2022] [Indexed: 11/13/2022] Open
Abstract
Kidney diseases represent a major public health problem, affecting millions of people worldwide. Moreover, the treatment of kidney diseases is burdened by the problematic effects of conventional drug delivery, such as systemic drug toxicity, rapid drug clearance, and the absence of precise targeting of the kidney. Although the use of nanotechnology in medicine is in its early stage and lacks robust translational studies, nanomedicines have already shown great promise as novel drug-delivery systems for the treatment of kidney disease. On the basis of our current knowledge of renal anatomy and physiology, pathophysiology of kidney diseases, and physicochemical characteristics of nanoparticles, an expansive repertoire and wide use of nanomedicines could be developed for kidney diseases in the near future. Some limitations have slowed the transition of these agents from preclinical studies to clinical trials, however. In this review, we summarize the current knowledge on renal drug-delivery systems and recent advances in renal cell targeting; we also demonstrate their important potential as future paradigm-shifting therapies for kidney diseases.
Collapse
Affiliation(s)
- Gianmarco Sabiu
- Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
- School of Nephrology, University of Milan, Milan, Italy
| | - Vivek Kasinath
- Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| | - Sungwook Jung
- Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| | - Xiaofei Li
- Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| | - George C Tsokos
- Division of Rheumatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
| | - Reza Abdi
- Transplantation Research Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
| |
Collapse
|
8
|
Nanodrugs alleviate acute kidney injury: Manipulate RONS at kidney. Bioact Mater 2023; 22:141-167. [PMID: 36203963 PMCID: PMC9526023 DOI: 10.1016/j.bioactmat.2022.09.021] [Citation(s) in RCA: 28] [Impact Index Per Article: 28.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2022] [Revised: 08/12/2022] [Accepted: 09/19/2022] [Indexed: 02/06/2023] Open
Abstract
Currently, there are no clinical drugs available to treat acute kidney injury (AKI). Given the high prevalence and high mortality rate of AKI, the development of drugs to effectively treat AKI is a huge unmet medical need and a research hotspot. Although existing evidence fully demonstrates that reactive oxygen and nitrogen species (RONS) burst at the AKI site is a major contributor to AKI progression, the heterogeneity, complexity, and unique physiological structure of the kidney make most antioxidant and anti-inflammatory small molecule drugs ineffective because of the lack of kidney targeting and side effects. Recently, nanodrugs with intrinsic kidney targeting through the control of size, shape, and surface properties have opened exciting prospects for the treatment of AKI. Many antioxidant nanodrugs have emerged to address the limitations of current AKI treatments. In this review, we systematically summarized for the first time about the emerging nanodrugs that exploit the pathological and physiological features of the kidney to overcome the limitations of traditional small-molecule drugs to achieve high AKI efficacy. First, we analyzed the pathological structural characteristics of AKI and the main pathological mechanism of AKI: hypoxia, harmful substance accumulation-induced RONS burst at the renal site despite the multifactorial initiation and heterogeneity of AKI. Subsequently, we introduced the strategies used to improve renal targeting and reviewed advances of nanodrugs for AKI: nano-RONS-sacrificial agents, antioxidant nanozymes, and nanocarriers for antioxidants and anti-inflammatory drugs. These nanodrugs have demonstrated excellent therapeutic effects, such as greatly reducing oxidative stress damage, restoring renal function, and low side effects. Finally, we discussed the challenges and future directions for translating nanodrugs into clinical AKI treatment. AKI is a common clinical acute syndrome with high morbidity and mortality but without effective clinical drug available. Hypoxia and accumulation of toxic substances are key pathological features of various heterogeneous AKI. Excessive RONS is the core of the pathological mechanism of AKI. The development of nanodrugs is expected to achieve successful treatment in AKI.
Collapse
|
9
|
Xiao Y, Pang YX, Yan Y, Qian P, Zhao H, Manickam S, Wu T, Pang CH. Synthesis and Functionalization of Graphene Materials for Biomedical Applications: Recent Advances, Challenges, and Perspectives. ADVANCED SCIENCE (WEINHEIM, BADEN-WURTTEMBERG, GERMANY) 2023; 10:e2205292. [PMID: 36658693 PMCID: PMC10037997 DOI: 10.1002/advs.202205292] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 09/14/2022] [Revised: 12/05/2022] [Indexed: 06/17/2023]
Abstract
Since its discovery in 2004, graphene is increasingly applied in various fields owing to its unique properties. Graphene application in the biomedical domain is promising and intriguing as an emerging 2D material with a high surface area, good mechanical properties, and unrivalled electronic and physical properties. This review summarizes six typical synthesis methods to fabricate pristine graphene (p-G), graphene oxide (GO), and reduced graphene oxide (rGO), followed by characterization techniques to examine the obtained graphene materials. As bare graphene is generally undesirable in vivo and in vitro, functionalization methods to reduce toxicity, increase biocompatibility, and provide more functionalities are demonstrated. Subsequently, in vivo and in vitro behaviors of various bare and functionalized graphene materials are discussed to evaluate the functionalization effects. Reasonable control of dose (<20 mg kg-1 ), sizes (50-1000 nm), and functionalization methods for in vivo application are advantageous. Then, the key biomedical applications based on graphene materials are discussed, coupled with the current challenges and outlooks of this growing field. In a broader sense, this review provides a comprehensive discussion on the synthesis, characterization, functionalization, evaluation, and application of p-G, GO, and rGO in the biomedical field, highlighting their recent advances and potential.
Collapse
Affiliation(s)
- Yuqin Xiao
- Department of Chemical and Environmental EngineeringUniversity of Nottingham Ningbo ChinaNingbo315100P. R. China
- New Materials InstituteUniversity of NottinghamNingbo315100P. R. China
- Materials Interfaces CenterShenzhen Institute of Advanced TechnologyChinese Academy of SciencesShenzhenGuangdong518055P. R. China
| | - Yoong Xin Pang
- Department of Chemical and Environmental EngineeringUniversity of Nottingham Ningbo ChinaNingbo315100P. R. China
- New Materials InstituteUniversity of NottinghamNingbo315100P. R. China
| | - Yuxin Yan
- College of Energy EngineeringZhejiang UniversityHangzhouZhejiang310027P. R. China
| | - Ping Qian
- Beijing Advanced Innovation Center for Materials Genome EngineeringBeijing100083P. R. China
- School of Mathematics and PhysicsUniversity of Science and Technology BeijingBeijing100083P. R. China
| | - Haitao Zhao
- Materials Interfaces CenterShenzhen Institute of Advanced TechnologyChinese Academy of SciencesShenzhenGuangdong518055P. R. China
| | - Sivakumar Manickam
- Petroleum and Chemical EngineeringFaculty of EngineeringUniversiti Teknologi BruneiBandar Seri BegawanBE1410Brunei Darussalam
| | - Tao Wu
- New Materials InstituteUniversity of NottinghamNingbo315100P. R. China
- Key Laboratory for Carbonaceous Wastes Processing and ProcessIntensification Research of Zhejiang ProvinceUniversity of Nottingham Ningbo ChinaNingbo315100P. R. China
| | - Cheng Heng Pang
- Department of Chemical and Environmental EngineeringUniversity of Nottingham Ningbo ChinaNingbo315100P. R. China
- Municipal Key Laboratory of Clean Energy Conversion TechnologiesUniversity of Nottingham Ningbo ChinaNingbo315100P. R. China
| |
Collapse
|
10
|
Renal clearance of graphene oxide: glomerular filtration or tubular secretion and selective kidney injury association with its lateral dimension. J Nanobiotechnology 2023; 21:51. [PMID: 36765370 PMCID: PMC9913007 DOI: 10.1186/s12951-023-01781-x] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2022] [Accepted: 01/12/2023] [Indexed: 02/12/2023] Open
Abstract
BACKGROUND Renal excretion is one of the major routes of nanomaterial elimination from the body. Many previous studies have found that graphene oxide nanosheets are excreted in bulk through the kidneys. However, how the lateral size affects GO disposition in the kidneys including glomerular filtration, active tubular secretion and tubular reabsorption is still unknown. RESULTS The thin, two-dimensional graphene oxide nanosheets (GOs) was observed to excrete in urine through the kidneys, but the lateral dimension of GOs affects their renal clearance pathway and renal injury. The s-GOs could be renal excreted via the glomerular filtration, while the l-GOs were predominately excreted via proximal tubular secretion at a much faster renal clearance rate than the s-GOs. For the tubular secretion of l-GOs, the mRNA level of basolateral organic anion transporters Oat1 and Oat2 in the kidney presented dose dependent increase, while no obvious alterations of the efflux transporters such as Mdr1 and Mrp4 mRNA expression levels were observed, suggesting the accumulation of l-GOs. During the GO renal elimination, mostly the high dose of 15 mg/kg s-GO and l-GO treatment showed obvious kidney injuries but at different renal compartment, i.e., the s-GOs induced obvious glomerular changes in podocytes, while the l-GOs induced more obvious tubular injuries including necrosis of renal tubular epithelial cells, loss of brush border, cast formation and tubular dilatation. The specifically tubular injury biomarkers KIM1 and NGAL were shown slight increase with mRNA levels in l-GO administrated mice. CONCLUSIONS This study shows that the lateral size of GOs affected their interactions with different renal compartments, renal excretion pathways and potential kidney injuries.
Collapse
|
11
|
Cong Y, Baimanov D, Zhou Y, Chen C, Wang L. Penetration and translocation of functional inorganic nanomaterials into biological barriers. Adv Drug Deliv Rev 2022; 191:114615. [PMID: 36356929 DOI: 10.1016/j.addr.2022.114615] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2022] [Revised: 10/23/2022] [Accepted: 11/02/2022] [Indexed: 11/09/2022]
Abstract
With excellent physicochemical properties, inorganic nanomaterials (INMs) have exhibited a series of attractive applications in biomedical fields. Biological barriers prevent successful delivery of nanomedicine in living systems that limits the development of nanomedicine especially for sufficient delivery of drugs and effective therapy. Numerous researches have focused on overcoming these biological barriers and homogeneity of organisms to enhance therapeutic efficacy, however, most of these strategies fail to resolve these challenges. In this review, we present the latest progress about how INMs interact with biological barriers and penetrate these barriers. We also summarize that both native structure and components of biological barriers and physicochemical properties of INMs contributed to the penetration capacity. Knowledge about the relationship between INMs structure and penetration capacity will guide the design and application of functional and efficient nanomedicine in the future.
Collapse
Affiliation(s)
- Yalin Cong
- CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China & Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, PR China; University of Chinese Academy of Sciences, Beijing 100049, PR China; CAS-HKU Joint Laboratory of Metallomics on Health and Environment, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, PR China
| | - Didar Baimanov
- CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China & Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, PR China; University of Chinese Academy of Sciences, Beijing 100049, PR China; CAS-HKU Joint Laboratory of Metallomics on Health and Environment, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, PR China; Engineering Research Center of Clinical Functional Materials and Diagnosis & Treatment Devices of Zhejiang Province, Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou 325000, PR China
| | - Yunlong Zhou
- Engineering Research Center of Clinical Functional Materials and Diagnosis & Treatment Devices of Zhejiang Province, Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou 325000, PR China
| | - Chunying Chen
- CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China & Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, PR China; University of Chinese Academy of Sciences, Beijing 100049, PR China; GBA Research Innovation Institute for Nanotechnology, Guangzhou 510700, Guangdong, PR China; Research Unit of Nanoscience and Technology, Chinese Academy of Medical Sciences, Beijing 100730, PR China
| | - Liming Wang
- CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China & Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, PR China; University of Chinese Academy of Sciences, Beijing 100049, PR China; CAS-HKU Joint Laboratory of Metallomics on Health and Environment, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing 100049, PR China.
| |
Collapse
|
12
|
Understanding the Role of the Lateral Dimensional Property of Graphene Oxide on Its Interactions with Renal Cells. Molecules 2022; 27:molecules27227956. [PMID: 36432058 PMCID: PMC9697150 DOI: 10.3390/molecules27227956] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2022] [Revised: 11/10/2022] [Accepted: 11/11/2022] [Indexed: 11/19/2022] Open
Abstract
Renal excretion is expected to be the major route for the elimination of biomedically applied nanoparticles from the body. Hence, understanding the nanomedicine-kidney interaction is crucially required, but it is still far from being understood. Herein, we explored the lateral dimension- (~70 nm and ~300 nm), dose- (1, 5, and 15 mg/kg in vivo and 0.1~250 μg/mL in vitro), and time-dependent (48 h and 7 d in vivo) deposition and injury of PEGylated graphene oxide sheets (GOs) in the kidney after i.v. injection in mice. We specially investigated the cytotoxic effects on three typical kidney cell types with which GO renal excretion is related: human renal glomerular endothelial cells (HRGECs) and human podocytes, and human proximal tubular epithelial cells (HK-2). By using in vivo fluorescence imaging and in situ Raman imaging and spectroscopic analysis, we revealed that GOs could gradually be eliminated from the kidneys, where the glomeruli and renal tubules are their target deposition sites, but only the high dose of GO injection induced obvious renal histological and ultrastructural changes. We showed that the high-dose GO-induced cytotoxicity included a cell viability decrease and cellular apoptosis increase. GO uptake by renal cells triggered cellular membrane damage (intracellular LDH release) and increased levels of oxidative stress (ROS level elevation and a decrease in the balance of the GSH/GSSG ratio) accompanied by a mitochondrial membrane potential decrease and up-regulation of the expression of pro-inflammatory cytokines TNF-α and IL-18, resulting in cellular apoptosis. GO treatments activated Keap1/Nrf2 signaling; however, the antioxidant function of Nrf2 could be inhibited by apoptotic engagement. GO-induced cytotoxicity was demonstrated to be associated with oxidative stress and an inflammation reaction. Generally, the l-GOs presented more pronounced cytotoxicity and more severe cellular injury than s-GOs did, demonstrating lateral size-dependent toxicity to the renal cells. More importantly, GO-induced cytotoxicity was independent of renal cell type. The results suggest that the dosage of GOs in biomedical applications should be considered and that more attention should be paid to the ability of a high dose of GO to cause renal deposition and potential nephrotoxicity.
Collapse
|
13
|
Fan T, Yan L, He S, Hong Q, Ai F, He S, Ji T, Hu X, Ha E, Zhang B, Li Z, Zhang H, Chen X, Hu J. Biodistribution, degradability and clearance of 2D materials for their biomedical applications. Chem Soc Rev 2022; 51:7732-7751. [PMID: 36047060 DOI: 10.1039/d1cs01070k] [Citation(s) in RCA: 18] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Two-dimensional (2D) materials have evolved to be a class of rapidly advancing chemical entities in the biomedical field. Nevertheless, potential side effects and safety concerns severely limit their clinical translation. After administration, 2D materials cross multiple biological barriers and are distributed throughout the body. Only the portion that accumulates at the diseased sites exerts a therapeutic effect, whereas those distributed elsewhere may cause damage to healthy tissues and interference to normal physiological function of various organs. To achieve maximum therapeutic efficacy and minimum adverse effects simultaneously, the delivery of 2D materials must be targeted at diseased sites to reach therapeutic concentrations, and the materials must possess sufficient degradation and clearance rates to avoid long-term toxicity. Therefore, it is essential to understand the biodistribution and destiny of 2D materials in vivo. In this review, first, we provide a comprehensive picture of the strategies that are currently adopted for regulating the in vivo fate of 2D materials, including modulations of their size, surface properties, composition, and external stimuli. Second, we systematically review the biodistribution, degradation, and metabolism of several newly emerged 2D materials. Finally, we also discuss the development opportunities of 2D materials in the biomedical field and the challenges to be addressed.
Collapse
Affiliation(s)
- Taojian Fan
- College of Health Science and Environmental Engineering, Shenzhen Technology University, 518118, Shenzhen, China. .,Institute of Microscale Optoelectronics, and Otolaryngology Department of the First Affiliated Hospital, Shenzhen Second People's Hospital, Health Science Center, Shenzhen University, Shenzhen 518060, China.
| | - Li Yan
- College of Health Science and Environmental Engineering, Shenzhen Technology University, 518118, Shenzhen, China.
| | - Shiliang He
- College of Health Science and Environmental Engineering, Shenzhen Technology University, 518118, Shenzhen, China.
| | - Qiancun Hong
- College of Health Science and Environmental Engineering, Shenzhen Technology University, 518118, Shenzhen, China.
| | - Fujin Ai
- College of Health Science and Environmental Engineering, Shenzhen Technology University, 518118, Shenzhen, China.
| | - Shuqing He
- College of Health Science and Environmental Engineering, Shenzhen Technology University, 518118, Shenzhen, China.
| | - Tao Ji
- College of Health Science and Environmental Engineering, Shenzhen Technology University, 518118, Shenzhen, China.
| | - Xin Hu
- College of Health Science and Environmental Engineering, Shenzhen Technology University, 518118, Shenzhen, China.
| | - Enna Ha
- College of Health Science and Environmental Engineering, Shenzhen Technology University, 518118, Shenzhen, China.
| | - Bin Zhang
- Institute of Microscale Optoelectronics, and Otolaryngology Department of the First Affiliated Hospital, Shenzhen Second People's Hospital, Health Science Center, Shenzhen University, Shenzhen 518060, China.
| | - Zigang Li
- Pingshan Translational Medicine Center, Shenzhen Bay Laboratory, Shenzhen 518132, China.,Laboratory of Chemical Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, 518055, China
| | - Han Zhang
- Institute of Microscale Optoelectronics, and Otolaryngology Department of the First Affiliated Hospital, Shenzhen Second People's Hospital, Health Science Center, Shenzhen University, Shenzhen 518060, China.
| | - Xianfeng Chen
- School of Engineering, Institute for Bioengineering, The University of Edinburgh, King's Buildings, Mayfield Road, Edinburgh EH9 3JL, UK.
| | - Junqing Hu
- College of Health Science and Environmental Engineering, Shenzhen Technology University, 518118, Shenzhen, China. .,Pingshan Translational Medicine Center, Shenzhen Bay Laboratory, Shenzhen 518132, China
| |
Collapse
|
14
|
Guilbaud-Chéreau C, Dinesh B, Wagner L, Chaloin O, Ménard-Moyon C, Bianco A. Aromatic Dipeptide Homologue-Based Hydrogels for Photocontrolled Drug Release. NANOMATERIALS 2022; 12:nano12101643. [PMID: 35630862 PMCID: PMC9143549 DOI: 10.3390/nano12101643] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/09/2022] [Revised: 04/29/2022] [Accepted: 05/04/2022] [Indexed: 12/16/2022]
Abstract
Peptide-based hydrogels are considered of special importance due to their biocompatibility and biodegradability. They have a wide range of applications in the biomedical field, such as drug delivery, tissue engineering, wound healing, cell culture media, and biosensing. Nevertheless, peptide-based hydrogels composed of natural α-amino acids are limited for in vivo applications because of the possible degradation by proteolytic enzymes. To circumvent this issue, the incorporation of extra methylene groups within the peptide sequence and the protection of the terminal amino group can increase the enzymatic stability. In this context, we investigated the self-assembly capacity of aromatic dipeptides (Boc-α-diphenylalanine and Boc-α-dityrosine) and their β- and γ-homologues and developed stable hydrogels. Surprisingly, only the Boc-diphenylalanine analogues were able to self-assemble and form hydrogels. A model drug, l-ascorbic acid, and oxidized carbon nanotubes (CNTs) or graphene oxide were then incorporated into the hydrogels. Under near-infrared light irradiation, the photothermal effect of the carbon nanomaterials induced the destabilization of the gel structure, which caused the release of a high amount of drug, thus providing opportunities for photocontrolled on-demand drug release.
Collapse
|
15
|
Meneses J, van de Kemp T, Costa-Almeida R, Pereira R, Magalhães FD, Castilho M, Pinto AM. Fabrication of Polymer/Graphene Biocomposites for Tissue Engineering. Polymers (Basel) 2022; 14:1038. [PMID: 35267861 PMCID: PMC8914623 DOI: 10.3390/polym14051038] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/12/2022] [Revised: 02/26/2022] [Accepted: 02/26/2022] [Indexed: 12/10/2022] Open
Abstract
Graphene-based materials (GBM) are considered one of the 21st century's most promising materials, as they are incredibly light, strong, thin and have remarkable electrical and thermal properties. As a result, over the past decade, their combination with a diverse range of synthetic polymers has been explored in tissue engineering (TE) and regenerative medicine (RM). In addition, a wide range of methods for fabricating polymer/GBM scaffolds have been reported. This review provides an overview of the most recent advances in polymer/GBM composite development and fabrication, focusing on methods such as electrospinning and additive manufacturing (AM). As a future outlook, this work stresses the need for more in vivo studies to validate polymer/GBM composite scaffolds for TE applications, and gives insight on their fabrication by state-of-the-art processing technologies.
Collapse
Affiliation(s)
- João Meneses
- LEPABE, Faculdade de Engenharia, Universidade do Porto, Rua Roberto Frias, 4200-465 Porto, Portugal; (J.M.); (T.v.d.K.); (F.D.M.)
- International Iberian Nanotechnology Laboratory, 4715-330 Braga, Portugal
| | - Tom van de Kemp
- LEPABE, Faculdade de Engenharia, Universidade do Porto, Rua Roberto Frias, 4200-465 Porto, Portugal; (J.M.); (T.v.d.K.); (F.D.M.)
- i3S—Instituto de Investigação e Inovacão em Saúde, Universidade do Porto, 4200-135 Porto, Portugal; (R.C.-A.); (R.P.)
- INEB—Instituto de Engenharia Biomédica, Universidade do Porto, 4200-135 Porto, Portugal
- Department of Orthopedics, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands;
| | - Raquel Costa-Almeida
- i3S—Instituto de Investigação e Inovacão em Saúde, Universidade do Porto, 4200-135 Porto, Portugal; (R.C.-A.); (R.P.)
- INEB—Instituto de Engenharia Biomédica, Universidade do Porto, 4200-135 Porto, Portugal
| | - Rúben Pereira
- i3S—Instituto de Investigação e Inovacão em Saúde, Universidade do Porto, 4200-135 Porto, Portugal; (R.C.-A.); (R.P.)
- INEB—Instituto de Engenharia Biomédica, Universidade do Porto, 4200-135 Porto, Portugal
- ICBAS—Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, 4050-313 Porto, Portugal
| | - Fernão D. Magalhães
- LEPABE, Faculdade de Engenharia, Universidade do Porto, Rua Roberto Frias, 4200-465 Porto, Portugal; (J.M.); (T.v.d.K.); (F.D.M.)
| | - Miguel Castilho
- Department of Orthopedics, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands;
- Department of Biomedical Engineering, Eindhoven University of Technology, 5600 MB Eindhoven, The Netherlands
| | - Artur M. Pinto
- LEPABE, Faculdade de Engenharia, Universidade do Porto, Rua Roberto Frias, 4200-465 Porto, Portugal; (J.M.); (T.v.d.K.); (F.D.M.)
- i3S—Instituto de Investigação e Inovacão em Saúde, Universidade do Porto, 4200-135 Porto, Portugal; (R.C.-A.); (R.P.)
- INEB—Instituto de Engenharia Biomédica, Universidade do Porto, 4200-135 Porto, Portugal
| |
Collapse
|
16
|
Pan X, Cheng D, Ruan C, Hong Y, Lin C. Development of Graphene-Based Materials in Bone Tissue Engineaering. GLOBAL CHALLENGES (HOBOKEN, NJ) 2022; 6:2100107. [PMID: 35140982 PMCID: PMC8812920 DOI: 10.1002/gch2.202100107] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 09/30/2021] [Revised: 10/31/2021] [Indexed: 06/14/2023]
Abstract
Bone regeneration-related graphene-based materials (bGBMs) are increasingly attracting attention in tissue engineering due to their special physical and chemical properties. The purpose of this review is to quantitatively analyze mass academic literature in the field of bGBMs through scientometrics software CiteSpace, to demonstrate the rules and trends of bGBMs, thus to analyze and summarize the mechanisms behind the rules, and to provide clues for future research. First, the research status, hotspots, and frontiers of bGBMs are analyzed in an intuitively and vividly visualized way. Next, the extracted important subjects such as fabrication techniques, cytotoxicity, biodegradability, and osteoinductivity of bGBMs are presented, and the different mechanisms, in turn, are also discussed. Finally, photothermal therapy, which is considered an emerging area of application of bGBMs, is also presented. Based on this approach, this work finds that different studies report differing opinions on the biological properties of bGBMS due to the lack of consistency of GBMs preparation. Therefore, it is necessary to establish more standards in fabrication, characterization, and testing for bGBMs to further promote scientific progress and clinical translation.
Collapse
Affiliation(s)
- Xiaoling Pan
- College of StomatologyXinjiang Medical UniversityUrumqiXinjiang830011P. R. China
- Department of Oral Maxillofacial SurgeryShenzhen HospitalSouthern Medical UniversityShenzhen518000P. R. China
| | - Delin Cheng
- Research Center for Human Tissue and Organs DegenerationInstitute of Biomedicine and BiotechnologyShenzhen Institutes of Advanced TechnologyChinese Academy of SciencesShenzhen518055P. R. China
| | - Changshun Ruan
- Research Center for Human Tissue and Organs DegenerationInstitute of Biomedicine and BiotechnologyShenzhen Institutes of Advanced TechnologyChinese Academy of SciencesShenzhen518055P. R. China
| | - Yonglong Hong
- Department of Oral Maxillofacial SurgeryShenzhen HospitalSouthern Medical UniversityShenzhen518000P. R. China
| | - Cheng Lin
- Department of Oral Maxillofacial SurgeryShenzhen HospitalSouthern Medical UniversityShenzhen518000P. R. China
| |
Collapse
|
17
|
Renal Nano-drug delivery for acute kidney Injury: Current status and future perspectives. J Control Release 2022; 343:237-254. [PMID: 35085695 DOI: 10.1016/j.jconrel.2022.01.033] [Citation(s) in RCA: 29] [Impact Index Per Article: 14.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2021] [Revised: 01/19/2022] [Accepted: 01/20/2022] [Indexed: 12/11/2022]
Abstract
Acute kidney injury (AKI) causes considerable morbidity and mortality, particularly in the case of post-cardiac infarction or kidney transplantation; however, the site-specific accumulation of small molecule reno-protective agents for AKI has often proved ineffective due to dynamic fluid and solute excretion and non-selectivity, which impedes therapeutic efficacy. This article reviews the current status and future trajectories of renal nanomedicine research for AKI management from pharmacological and clinical perspectives, with a particular focus on appraising nanosized drug carrier (NDC) use for the delivery of reno-protective agents of different pharmacological classes and the effectiveness of NDCs in improving renal tissue targeting selectivity and efficacy of said agents. This review reveals the critical shift in the role of the small molecule reno-protective agents in AKI pharmacotherapy - from prophylaxis to treatment - when using NDCs for delivery to the kidney. We also highlight the need to identify the accumulation sites of NDCs carrying reno-protective agents in renal tissues during in vivo assessments and detail the less-explored pharmacological classes of reno-protective agents whose efficacies may be improved via NDC-based delivery. We conclude the paper by outlining the challenges and future perspectives of NDC-based reno-protective agent delivery for better clinical management of AKI.
Collapse
|
18
|
Xu XL, Zhang NN, Shu GF, Liu D, Qi J, Jin FY, Ji JS, Du YZ. A Luminol-Based Self-Illuminating Nanocage as a Reactive Oxygen Species Amplifier to Enhance Deep Tumor Penetration and Synergistic Therapy. ACS NANO 2021; 15:19394-19408. [PMID: 34806870 DOI: 10.1021/acsnano.1c05891] [Citation(s) in RCA: 23] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Abstract
The dense extracellular matrix (ECM) in tumor tissues resists drug diffusion into tumors and leads to a poor prognosis. To address this problem, glucose oxidase (GOx)-modified ferritin loaded with luminol-curcumin was fabricated. Once delivered to the tumor, this luminol-based self-illuminating nanocage could actively convert glucose to reactive oxygen species (ROS) to achieve starvation therapy. Then, excessive ROS were transmitted to luminol, thereby emitting 425 nm blue-violet light. Momentarily, light was further absorbed by curcumin and ROS production was amplified. Abundant ROS helps break down the ECM network to penetrate deep into tumors. In addition, ROS produced after cell internalization can induce apoptosis of tumor cells by decreasing the mitochondrial membrane potential and can promote ferroptosis by consuming reduced glutathione. Effective penetration and multiple pathways inducing tumor cell death contributed to the efficient antitumor effect (tumor inhibition rate of GOx-modified ferritin loaded with luminol-curcumin: 71.73%). This study developed a glucose-driven self-illuminating nanocage for active tumor penetration via ROS-mediated destruction of the ECM and provided the synergetic mechanism of apoptosis and ferroptosis.
Collapse
Affiliation(s)
- Xiao-Ling Xu
- Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, PR China
| | - Nan-Nan Zhang
- Key Laboratory of Imaging Diagnosis and Minimally Invasive Intervention Research, Lishui Hospital of Zhejiang University, Lishui 323000, China
| | - Gao-Feng Shu
- Key Laboratory of Imaging Diagnosis and Minimally Invasive Intervention Research, Lishui Hospital of Zhejiang University, Lishui 323000, China
| | - Di Liu
- Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, PR China
| | - Jing Qi
- Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, PR China
| | - Fei-Yang Jin
- Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, PR China
| | - Jian-Song Ji
- Key Laboratory of Imaging Diagnosis and Minimally Invasive Intervention Research, Lishui Hospital of Zhejiang University, Lishui 323000, China
| | - Yong-Zhong Du
- Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, PR China
| |
Collapse
|
19
|
Jasim DA, Newman L, Rodrigues AF, Vacchi IA, Lucherelli MA, Lozano N, Ménard-Moyon C, Bianco A, Kostarelos K. The impact of graphene oxide sheet lateral dimensions on their pharmacokinetic and tissue distribution profiles in mice. J Control Release 2021; 338:330-340. [PMID: 34418522 DOI: 10.1016/j.jconrel.2021.08.028] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2020] [Revised: 08/11/2021] [Accepted: 08/16/2021] [Indexed: 10/20/2022]
Abstract
Although the use of graphene and 2-dimensional (2D) materials in biomedicine has been explored for over a decade now, there are still significant knowledge gaps regarding the fate of these materials upon interaction with living systems. Here, the pharmacokinetic profile of graphene oxide (GO) sheets of three different lateral dimensions was studied. The GO materials were functionalized with a PEGylated DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid), a radiometal chelating agent for radioisotope attachment for single photon emission computed tomography (SPECT/CT) imaging. Our results revealed that GO materials with three distinct size distributions, large (l-GO-DOTA), small (s-GO-DOTA) and ultra-small (us-GO-DOTA), were sequestered by the spleen and liver. Significant accumulation of the large material (l-GO-DOTA) in the lungs was also observed, unlike the other two materials. Interestingly, there was extensive urinary excretion of all three GO nanomaterials indicating that urinary excretion of these structures was not affected by lateral dimensions. Comparing with previous studies, we believe that the thickness of layered nanomaterials is the predominant factor that governs their excretion rather than lateral size. However, the rate of urinary excretion was affected by lateral size, with large GO excreting at slower rates. This study provides better understanding of 2D materials in vivo behaviour with varying structural features.
Collapse
Affiliation(s)
- Dhifaf A Jasim
- Nanomedicine Lab, National Graphene Institute, Faculty of Biology, Medicine & Health, University of Manchester, AV Hill Building, Manchester M13 9PT, United Kingdom
| | - Leon Newman
- Nanomedicine Lab, National Graphene Institute, Faculty of Biology, Medicine & Health, University of Manchester, AV Hill Building, Manchester M13 9PT, United Kingdom
| | - Artur Filipe Rodrigues
- Nanomedicine Lab, National Graphene Institute, Faculty of Biology, Medicine & Health, University of Manchester, AV Hill Building, Manchester M13 9PT, United Kingdom
| | - Isabella A Vacchi
- CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR3572, University of Strasbourg, Strasbourg 67000, France
| | - Matteo A Lucherelli
- CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR3572, University of Strasbourg, Strasbourg 67000, France
| | - Neus Lozano
- Nanomedicine Lab, National Graphene Institute, Faculty of Biology, Medicine & Health, University of Manchester, AV Hill Building, Manchester M13 9PT, United Kingdom; Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Bellaterra, 08193 Barcelona, Spain
| | - Cécilia Ménard-Moyon
- CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR3572, University of Strasbourg, Strasbourg 67000, France
| | - Alberto Bianco
- CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR3572, University of Strasbourg, Strasbourg 67000, France
| | - Kostas Kostarelos
- Nanomedicine Lab, National Graphene Institute, Faculty of Biology, Medicine & Health, University of Manchester, AV Hill Building, Manchester M13 9PT, United Kingdom; Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Bellaterra, 08193 Barcelona, Spain.
| |
Collapse
|
20
|
Myla A, Dasmahapatra AK, Tchounwou PB. Sex-reversal and Histopathological Assessment of Potential Endocrine-Disrupting Effects of Graphene Oxide on Japanese medaka (Oryzias latipes) Larvae. CHEMOSPHERE 2021; 279:130768. [PMID: 34134430 PMCID: PMC8217731 DOI: 10.1016/j.chemosphere.2021.130768] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/11/2021] [Revised: 04/24/2021] [Accepted: 04/28/2021] [Indexed: 05/12/2023]
Abstract
Sex-ratio is considered as an end point during endocrine disrupting chemicals (EDCs) evaluation. Many fish species including Japanese medaka have XX/XY sex determination mechanism, however, sex reversal (SR) can be induced by external and genetic factors. SR imposed an imbalance in natural sex ratio of a population living in any ecosystem. Considering SR as an end point, we aimed to investigate the potential EDC effects of graphene oxide (GO), a nanocarbon, using Japanese medaka as a model. One-day post-hatch (dph) medaka fries were exposed to GO (2.5, 5.0, 10.0 and 20 mg/L) for 96 h without food, followed by 6 weeks depuration in a GO-free environment with feeding. Phenotypic sex was determined by gonad histology; genotypic sex by genotyping Y-chromosome-specific male sex determining gene, dmy. Our data indicated testes in both XY and XX genotypes, while ovaries were only in XX females. Histopathology of XY and XX testis showed isogenic spermatocysts with active spermatogenesis. Distribution of spermatocytes (SPTs), not the spermatogonium (SPGs), showed enhancement in XY than XX testis. Female phenotypes had single ovary, either in stage 0 or 1. Ovo-testis/testis-ova were absent in XX or XY gonads. GO (2.5-20 mg/L) had inconsistent concentration-dependent effect in both SPGs and SPTs; however, no effect on ovarian follicles. Despite genotypic differences (XY/XX), in the histopathology/histochemistry of liver and kidneys GO effects was found to be minimum. Taken together, present study showed spontaneous induction of SR in some XX genotypes; however, exposure of fasting fries to GO had no apparent EDC effects.
Collapse
Affiliation(s)
- Anitha Myla
- RCMI Center for Environmental Health, Jackson State University, Jackson, MS, 39217, USA
| | - Asok K Dasmahapatra
- RCMI Center for Environmental Health, Jackson State University, Jackson, MS, 39217, USA; Department of BioMolecular Sciences, Environmental Toxicology Division, University of Mississippi, University, MS, 38677, USA
| | - Paul B Tchounwou
- RCMI Center for Environmental Health, Jackson State University, Jackson, MS, 39217, USA.
| |
Collapse
|
21
|
Abstract
The kidneys are vital organs performing several essential functions. Their primary function is the filtration of blood and the removal of metabolic waste products as well as fluid homeostasis. Renal filtration is the main pathway for drug removal, highlighting the importance of this organ to the growing field of nanomedicine. The kidneys (i) have a key role in the transport and clearance of nanoparticles (NPs), (ii) are exposed to potential NPs’ toxicity, and (iii) are the targets of diseases that nanomedicine can study, detect, and treat. In this review, we aim to summarize the latest research on kidney-nanoparticle interaction. We first give a brief overview of the kidney’s anatomy and renal filtration, describe how nanoparticle characteristics influence their renal clearance, and the approaches taken to image and treat the kidney, including drug delivery and tissue engineering. Finally, we discuss the future and some of the challenges faced by nanomedicine.
Collapse
|
22
|
Synthesis and Toxicity of Graphene Oxide Nanoparticles: A Literature Review of In Vitro and In Vivo Studies. BIOMED RESEARCH INTERNATIONAL 2021; 2021:5518999. [PMID: 34222470 PMCID: PMC8213470 DOI: 10.1155/2021/5518999] [Citation(s) in RCA: 69] [Impact Index Per Article: 23.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/09/2021] [Revised: 04/11/2021] [Accepted: 05/29/2021] [Indexed: 11/18/2022]
Abstract
Nanomaterials have been widely used in many fields in the last decades, including electronics, biomedicine, cosmetics, food processing, buildings, and aeronautics. The application of these nanomaterials in the medical field could improve diagnosis, treatment, and prevention techniques. Graphene oxide (GO), an oxidized derivative of graphene, is currently used in biotechnology and medicine for cancer treatment, drug delivery, and cellular imaging. Also, GO is characterized by various physicochemical properties, including nanoscale size, high surface area, and electrical charge. However, the toxic effect of GO on living cells and organs is a limiting factor that limits its use in the medical field. Recently, numerous studies have evaluated the biocompatibility and toxicity of GO in vivo and in vitro. In general, the severity of this nanomaterial's toxic effects varies according to the administration route, the dose to be administered, the method of GO synthesis, and its physicochemical properties. This review brings together studies on the method of synthesis and structure of GO, characterization techniques, and physicochemical properties. Also, we rely on the toxicity of GO in cellular models and biological systems. Moreover, we mention the general mechanism of its toxicity.
Collapse
|
23
|
Huang X, Ma Y, Li Y, Han F, Lin W. Targeted Drug Delivery Systems for Kidney Diseases. Front Bioeng Biotechnol 2021; 9:683247. [PMID: 34124026 PMCID: PMC8193852 DOI: 10.3389/fbioe.2021.683247] [Citation(s) in RCA: 21] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2021] [Accepted: 04/27/2021] [Indexed: 12/12/2022] Open
Abstract
Kidney diseases have gradually become a global health burden. Along with the development of nanotechnology, many hybrids or nanomaterials have been utilized to promote treatment efficiency with negligible side effects. These therapeutic agents have been successfully applied in many fields. In particular, some efforts have also been made to ameliorate the treatment of kidney diseases through targeted delivery nanomaterials. Though most of the delivery systems have not yet been transmitted into clinical use or even still at an early stage, they have shown great potential in carrying immunosuppressants like tacrolimus and triptolide, antioxidants, or siRNAs. Excitingly, some of them have achieved significant treatment effectiveness and reduced systemic side effect in kidney disease animal models. Here, we have reviewed the recent advances and presented nanotherapeutic devices designed for kidney targeted delivery.
Collapse
Affiliation(s)
- Xiaohan Huang
- Key Laboratory of Kidney Disease Prevention and Control Technology, Kidney Disease Center, Zhejiang University School of Medicine, The First Affiliated Hospital, Institute of Nephrology, Zhejiang University, Hangzhou, China
| | - Yanhong Ma
- Key Laboratory of Kidney Disease Prevention and Control Technology, Kidney Disease Center, Zhejiang University School of Medicine, The First Affiliated Hospital, Institute of Nephrology, Zhejiang University, Hangzhou, China
| | - Yangyang Li
- Key Laboratory of Women's Reproductive Health Research of Zhejiang Province, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Fei Han
- Key Laboratory of Kidney Disease Prevention and Control Technology, Kidney Disease Center, Zhejiang University School of Medicine, The First Affiliated Hospital, Institute of Nephrology, Zhejiang University, Hangzhou, China
| | - Weiqiang Lin
- Department of Nephrology, The Fourth Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine, Jinhua, China
| |
Collapse
|
24
|
Kamali Shahri SM, Sharifi S, Mahmoudi M. Interdependency of influential parameters in therapeutic nanomedicine. Expert Opin Drug Deliv 2021; 18:1379-1394. [PMID: 33887999 DOI: 10.1080/17425247.2021.1921732] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
Introduction:Current challenges to successful clinical translation of therapeutic nanomedicine have discouraged many stakeholders, including patients. Significant effort has been devoted to uncovering the reasons behind the less-than-expected success, beyond failures or ineffectiveness, of therapeutic nanomedicine products (e.g. cancer nanomedicine). Until we understand and address the factors that limit the safety and efficacy of NPs, both individually and in combination, successful clinical development will lag.Areas covered:This review highlights the critical roles of interdependent factors affecting the safety and therapeutic efficacy of therapeutic NPs for drug delivery applications.Expert opinion:Deep analysis of the current nanomedical literature reveals ahistory of unanticipated complexity by awide range of stakeholders including researchers. In the manufacture of nanomedicines themselves, there have been persistent difficulties with reproducibility and batch-to-batch variation. The unanticipated complexity and interdependency of nano-bio parameters has delayed our recognition of important factors affecting the safety and therapeutic efficacy of nanomedicine products. These missteps have had many factors including our lack of understanding of the interdependency of various factors affecting the biological identity and fate of NPs and biased interpretation of data. All these issues could raise significant concern regarding the reproducibility- or even the validity- of past publications that in turn formed the basis of many clinical trials of therapeutic nanomedicines. Therefore, the individual and combined effects of previously overlooked factors on the safety and therapeutic efficacy of NPs need to be fully considered in nanomedicine reports and product development.
Collapse
Affiliation(s)
- Seyed Mehdi Kamali Shahri
- Department of Radiology and Precision Health Program, College of Human Medicine, Michigan State University, East Lansing, MI, USA
| | - Shahriar Sharifi
- Department of Radiology and Precision Health Program, College of Human Medicine, Michigan State University, East Lansing, MI, USA
| | - Morteza Mahmoudi
- Department of Radiology and Precision Health Program, College of Human Medicine, Michigan State University, East Lansing, MI, USA
| |
Collapse
|
25
|
Iwakura T, Marschner JA, Zhao ZB, Świderska MK, Anders HJ. Electric cell-substrate impedance sensing in kidney research. Nephrol Dial Transplant 2021; 36:216-223. [PMID: 31598727 DOI: 10.1093/ndt/gfz191] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2019] [Accepted: 08/18/2019] [Indexed: 12/20/2022] Open
Abstract
Electric cell-substrate impedance sensing (ECIS) is a quantitative, label-free, non-invasive analytical method allowing continuous monitoring of the behaviour of adherent cells by online recording of transcellular impedance. ECIS offers a wide range of practical applications to study cell proliferation, migration, differentiation, toxicity and monolayer barrier integrity. All of these applications are relevant for basic kidney research, e.g. on endothelial cells, tubular and glomerular epithelial cells. This review gives an overview on the fundamental principles of the ECIS technology. We name strengths and remaining hurdles for practical applications, present an ECIS array reuse protocol, and review its past, present and potential future contributions to preclinical kidney research.
Collapse
Affiliation(s)
- Takamasa Iwakura
- Renal Division, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, LMU Munich, München, Germany.,Internal Medicine I, Division of Nephrology, Hamamatsu University School of Medicine, Hamamatsu, Japan
| | - Julian A Marschner
- Renal Division, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, LMU Munich, München, Germany
| | - Zhi Bo Zhao
- Renal Division, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, LMU Munich, München, Germany
| | - Monika Katarzyna Świderska
- Renal Division, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, LMU Munich, München, Germany
| | - Hans-Joachim Anders
- Renal Division, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, LMU Munich, München, Germany
| |
Collapse
|
26
|
Magne TM, de Oliveira Vieira T, Costa B, Alencar LMR, Ricci-Junior E, Hu R, Qu J, Zamora-Ledezma C, Alexis F, Santos-Oliveira R. Factors affecting the biological response of Graphene. Colloids Surf B Biointerfaces 2021; 203:111767. [PMID: 33878553 DOI: 10.1016/j.colsurfb.2021.111767] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2020] [Revised: 03/26/2021] [Accepted: 04/12/2021] [Indexed: 12/23/2022]
Abstract
Nanotechnology has gained significant importance in different fields of medical, electronic, and environmental science. This technology is founded on the use of materials at the nanoscale scale (1-100 nanometers) for various purposes, particularly in the biomedical area, where its application is growing daily due to the need of materials with advanced properties. Over the past few years, there has been a growing use for graphene and its derivative composite materials. However, different physico-chemical properties influence its biological response; therefore, further studies to explain the interactions of these nanomaterials with biological systems are critical. This review presents the current advances in the applications of graphene in biomedicine with a focus on the physico-chemical characteristics of the graphene family and their influences on biological interactions.
Collapse
Affiliation(s)
- Tais Monteiro Magne
- Brazilian Nuclear Energy Commission, Nuclear Engineering Institute, Laboratory of Novel Radiopharmaceuticals and Nanoradiopharmacy, R. Helio de Almeida, 75, Rio de Janeiro, 21941906, Brazil
| | - Thamires de Oliveira Vieira
- Brazilian Nuclear Energy Commission, Nuclear Engineering Institute, Laboratory of Novel Radiopharmaceuticals and Nanoradiopharmacy, R. Helio de Almeida, 75, Rio de Janeiro, 21941906, Brazil
| | - Bianca Costa
- Brazilian Nuclear Energy Commission, Nuclear Engineering Institute, Laboratory of Novel Radiopharmaceuticals and Nanoradiopharmacy, R. Helio de Almeida, 75, Rio de Janeiro, 21941906, Brazil
| | | | - Eduardo Ricci-Junior
- Federal University of Rio de Janeiro, Laboratory of Nanomedicine, Av. Carlos Chagas Filho, 373, Cidade Universitária da Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, 21941-170, Brazil
| | - Rui Hu
- Key Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, College of Optoelectronic Engineering, Shenzhen University, Shenzhen, 518060, PR China
| | - Junle Qu
- Key Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, College of Optoelectronic Engineering, Shenzhen University, Shenzhen, 518060, PR China
| | - Camilo Zamora-Ledezma
- Tissue Regeneration and Repair: Orthobiology, Biomaterials & Tissue Engineering Group. UCAM - Universidad Católica de Murcia, Avda. Los Jerónimos 135, Guadalupe, 30107, Murcia, Spain
| | - Frank Alexis
- School of Physical Sciences and Nanotechnology, Yachay Tech University, 100119, Urcuquí, Ecuador
| | - Ralph Santos-Oliveira
- Brazilian Nuclear Energy Commission, Nuclear Engineering Institute, Laboratory of Novel Radiopharmaceuticals and Nanoradiopharmacy, R. Helio de Almeida, 75, Rio de Janeiro, 21941906, Brazil; Zona Oeste State University, Laboratory of Nanoradiopharmacy and Synthesis of Radiopharmaceuticals, Av Manuel caldeira de Alvarenga, 200, Campo Grande, Rio de Janeiro, 2100000, Brazil.
| |
Collapse
|
27
|
Poon W, Kingston BR, Ouyang B, Ngo W, Chan WCW. A framework for designing delivery systems. NATURE NANOTECHNOLOGY 2020; 15:819-829. [PMID: 32895522 DOI: 10.1038/s41565-020-0759-5] [Citation(s) in RCA: 276] [Impact Index Per Article: 69.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/08/2020] [Accepted: 07/30/2020] [Indexed: 05/22/2023]
Abstract
The delivery of medical agents to a specific diseased tissue or cell is critical for diagnosing and treating patients. Nanomaterials are promising vehicles to transport agents that include drugs, contrast agents, immunotherapies and gene editors. They can be engineered to have different physical and chemical properties that influence their interactions with their biological environments and delivery destinations. In this Review Article, we discuss nanoparticle delivery systems and how the biology of disease should inform their design. We propose developing a framework for building optimal delivery systems that uses nanoparticle-biological interaction data and computational analyses to guide future nanomaterial designs and delivery strategies.
Collapse
Affiliation(s)
- Wilson Poon
- Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada
- Terrence Donnelly Centre for Cellular & Biomolecular Research, University of Toronto, Toronto, Ontario, Canada
| | - Benjamin R Kingston
- Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada
- Terrence Donnelly Centre for Cellular & Biomolecular Research, University of Toronto, Toronto, Ontario, Canada
| | - Ben Ouyang
- Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada
- Terrence Donnelly Centre for Cellular & Biomolecular Research, University of Toronto, Toronto, Ontario, Canada
- MD/PhD Program, University of Toronto, Toronto, Ontario, Canada
| | - Wayne Ngo
- Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada
- Terrence Donnelly Centre for Cellular & Biomolecular Research, University of Toronto, Toronto, Ontario, Canada
| | - Warren C W Chan
- Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada.
- Terrence Donnelly Centre for Cellular & Biomolecular Research, University of Toronto, Toronto, Ontario, Canada.
- Department of Chemical Engineering & Applied Chemistry, University of Toronto, Toronto, Ontario, Canada.
- Department of Materials Science & Engineering, University of Toronto, Toronto, Ontaro, Canada.
- Department of Chemistry, University of Toronto, Toronto, Ontario, Canada.
| |
Collapse
|
28
|
Nguyen EP, de Carvalho Castro Silva C, Merkoçi A. Recent advancement in biomedical applications on the surface of two-dimensional materials: from biosensing to tissue engineering. NANOSCALE 2020; 12:19043-19067. [PMID: 32960195 DOI: 10.1039/d0nr05287f] [Citation(s) in RCA: 29] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
As biosensors and biomedical devices have become increasingly important to everyday diagnostics and monitoring, there are tremendous, and constant efforts towards developing and improving the reliability and versatility of such technology. As they offer high surface area-to-volume ratios and a diverse range of properties, from electronic to optical, two dimensional (2D) materials have proven to be very promising candidates for biological applications and technologies. Due to the dimensionality, 2D materials facilitate many interfacial phenomena that have shown to significantly improve the performance of biosensors, while recent advances in synthesis techniques and surface engineering methods also enable the realization of future biomedical devices. This short review aims to highlight the influence of 2D material surfaces and the properties that arise due to their 2D structure. Using recent (within the last few years) examples of biosensors and biomedical applications, we emphasize the important role of 2D materials in advancing developments and research for biosensing and healthcare.
Collapse
Affiliation(s)
- Emily P Nguyen
- Nanobioelectronics & Biosensors Group, Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Bellaterra, 08193, Barcelona, Spain.
| | - Cecilia de Carvalho Castro Silva
- Nanobioelectronics & Biosensors Group, Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Bellaterra, 08193, Barcelona, Spain. and MackGraphe - Graphene and Nanomaterials Research Center, Mackenzie Presbyterian University, 01302-907, São Paulo, Brazil
| | - Arben Merkoçi
- Nanobioelectronics & Biosensors Group, Catalan Institute of Nanoscience and Nanotechnology (ICN2), CSIC and BIST, Campus UAB, Bellaterra, 08193, Barcelona, Spain. and ICREA Institució Catalana de Recerca i Estudis Avançats, Barcelona 08010, Spain
| |
Collapse
|
29
|
Jiang D, Rosenkrans ZT, Ni D, Lin J, Huang P, Cai W. Nanomedicines for Renal Management: From Imaging to Treatment. Acc Chem Res 2020; 53:1869-1880. [PMID: 32786331 DOI: 10.1021/acs.accounts.0c00323] [Citation(s) in RCA: 50] [Impact Index Per Article: 12.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
Nanomedicine has benefited from recent advances in chemistry and biomedical engineering to produce nanoscale materials as theranostic agents. Well-designed nanomaterials may present optimal biological properties, influencing circulation, retention, and excretion for imaging and treatment of various diseases. As the understanding of nanomedicine pharmacokinetics expands continuously, efficient renal clearance of nanomedicines can significantly increase the signal-to-background ratio for precision diagnosis and lower potential toxicity for improved treatment. Studies on nanomaterial-kidney interactions have led to many novel findings on the underlying principles of nanomaterial renal clearance, targeting, and accumulation. In return, the optimized nanomedicines confer significant benefits to the detection and treatment of kidney dysfunction.In this Account, we present an overview of recent progress in the development of nanomaterials for kidney theranostics, aiming to speed up translation and expand possible applications. We start by introducing biological structures of the kidney and their influence on renal targeting, retention, and clearance. Several key factors regarding renal accumulation and excretion, including nanomaterial types, sizes, and shapes, surface charges, and chemical modifications, are identified and discussed. Next, we highlight our recent efforts investigating kidney-interacting nanomaterials and introduce representative nanomedicines for imaging and treatment of kidney diseases. Multiple renal-clearable and renal-accumulating nanomedicines were devised for kidney function imaging. By employing renal-clearable nanomedicines, including gold nanoparticles, porphyrin polymers, DNA frameworks, and polyoxometalate clusters, we were able to noninvasively evaluate split renal function in healthy and diseased mice. Further engineering of renal-accumulating nanosystems has shifted attention from renal diagnosis to precision kidney protection. Many biocompatible nanomedicines, such as DNA origami, selenium-doped carbon quantum dots, melanin nanoparticles, and black phosphorus have all played essential roles in diminishing excessive reactive oxygen species for kidney treatment and protection. Finally, we discuss the challenges and perspectives of nanomaterials for renal care, their future clinical translation, and how they may affect the current landscape of clinical practices. We believe that this Account updates our current understanding of nanomaterial-kidney interactions for further design and control of nanomedicines for specific kidney diagnosis and treatment. This timely Account will generate broad interest in integrating nanotechnology and nanomaterial-biological interaction for state-of-the-art theranostics of renal diseases.
Collapse
Affiliation(s)
- Dawei Jiang
- Marshall Laboratory of Biomedical Engineering, International Cancer Center, Laboratory of Evolutionary Theranostics, School of Biomedical Engineering, Shenzhen University Health Science Center, Shenzhen, Guangzhou 518060, China
- Hubei Province Key Laboratory of Molecular Imaging, Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
- Departments of Radiology and Medical Physics, University of Wisconsin—Madison, Madison, Wisconsin 53705, United States
| | - Zachary T. Rosenkrans
- Department of Pharmaceutical Sciences, University of Wisconsin—Madison, Madison, Wisconsin 53705, United States
| | - Dalong Ni
- Departments of Radiology and Medical Physics, University of Wisconsin—Madison, Madison, Wisconsin 53705, United States
| | - Jing Lin
- Marshall Laboratory of Biomedical Engineering, International Cancer Center, Laboratory of Evolutionary Theranostics, School of Biomedical Engineering, Shenzhen University Health Science Center, Shenzhen, Guangzhou 518060, China
| | - Peng Huang
- Marshall Laboratory of Biomedical Engineering, International Cancer Center, Laboratory of Evolutionary Theranostics, School of Biomedical Engineering, Shenzhen University Health Science Center, Shenzhen, Guangzhou 518060, China
| | - Weibo Cai
- Departments of Radiology and Medical Physics, University of Wisconsin—Madison, Madison, Wisconsin 53705, United States
- Department of Pharmaceutical Sciences, University of Wisconsin—Madison, Madison, Wisconsin 53705, United States
| |
Collapse
|
30
|
Newman L, Jasim DA, Prestat E, Lozano N, de Lazaro I, Nam Y, Assas BM, Pennock J, Haigh SJ, Bussy C, Kostarelos K. Splenic Capture and In Vivo Intracellular Biodegradation of Biological-Grade Graphene Oxide Sheets. ACS NANO 2020; 14:10168-10186. [PMID: 32658456 PMCID: PMC7458483 DOI: 10.1021/acsnano.0c03438] [Citation(s) in RCA: 43] [Impact Index Per Article: 10.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/24/2020] [Accepted: 07/13/2020] [Indexed: 05/20/2023]
Abstract
Carbon nanomaterials, including 2D graphene-based materials, have shown promising applicability to drug delivery, tissue engineering, diagnostics, and various other biomedical areas. However, to exploit the benefits of these materials in some of the areas mentioned, it is necessary to understand their possible toxicological implications and long-term fate in vivo. We previously demonstrated that following intravenous administration, 2D graphene oxide (GO) nanosheets were largely excreted via the kidneys; however, a small but significant portion of the material was sequestered in the spleen. Herein, we interrogate the potential consequences of this accumulation and the fate of the spleen-residing GO over a period of nine months. We show that our thoroughly characterized GO materials are not associated with any detectable pathological consequences in the spleen. Using confocal Raman mapping of tissue sections, we determine the sub-organ biodistribution of GO at various time points after administration. The cells largely responsible for taking up the material are confirmed using immunohistochemistry coupled with Raman spectroscopy, and transmission electron microscopy (TEM). This combination of techniques identified cells of the splenic marginal zone as the main site of GO bioaccumulation. In addition, through analyses using both bright-field TEM coupled with electron diffraction and Raman spectroscopy, we reveal direct evidence of in vivo intracellular biodegradation of GO sheets with ultrastructural precision. This work offers critical information about biological processing and degradation of thin GO sheets by normal mammalian tissue, indicating that further development and exploitation of GO in biomedicine would be possible.
Collapse
Affiliation(s)
- Leon Newman
- Nanomedicine
Lab, National Graphene Institute and Faculty of Biology, Medicine
& Health, The University of Manchester, Manchester, M13 9PT, United Kingdom
| | - Dhifaf A. Jasim
- Nanomedicine
Lab, National Graphene Institute and Faculty of Biology, Medicine
& Health, The University of Manchester, Manchester, M13 9PT, United Kingdom
| | - Eric Prestat
- Department
of Materials, School of Natural Sciences, The University of Manchester, Manchester, M13 9PL, United Kingdom
| | - Neus Lozano
- Nanomedicine
Lab, National Graphene Institute and Faculty of Biology, Medicine
& Health, The University of Manchester, Manchester, M13 9PT, United Kingdom
- Catalan
Institute of Nanoscience and Nanotechnology (ICN2), Barcelona, 08193, Spain
| | - Irene de Lazaro
- Nanomedicine
Lab, National Graphene Institute and Faculty of Biology, Medicine
& Health, The University of Manchester, Manchester, M13 9PT, United Kingdom
| | - Yein Nam
- Nanomedicine
Lab, National Graphene Institute and Faculty of Biology, Medicine
& Health, The University of Manchester, Manchester, M13 9PT, United Kingdom
| | - Bakri M. Assas
- Lydia
Becker Institute of Immunology and Inflammation, and Division of Infection,
Immunity and Respiratory Medicine, School of Biological Sciences,
Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, M13 9PT, United Kingdom
- Department
of Immunology, Faculty of Applied Sciences, King Abdulaziz University, Jeddah, 21589, Saudi Arabia
| | - Joanne Pennock
- Lydia
Becker Institute of Immunology and Inflammation, and Division of Infection,
Immunity and Respiratory Medicine, School of Biological Sciences,
Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, M13 9PT, United Kingdom
| | - Sarah J. Haigh
- Department
of Materials, School of Natural Sciences, The University of Manchester, Manchester, M13 9PL, United Kingdom
| | - Cyrill Bussy
- Nanomedicine
Lab, National Graphene Institute and Faculty of Biology, Medicine
& Health, The University of Manchester, Manchester, M13 9PT, United Kingdom
| | - Kostas Kostarelos
- Nanomedicine
Lab, National Graphene Institute and Faculty of Biology, Medicine
& Health, The University of Manchester, Manchester, M13 9PT, United Kingdom
- Catalan
Institute of Nanoscience and Nanotechnology (ICN2), Barcelona, 08193, Spain
| |
Collapse
|
31
|
2D materials in electrochemical sensors for in vitro or in vivo use. Anal Bioanal Chem 2020; 413:701-725. [PMID: 32776222 DOI: 10.1007/s00216-020-02831-1] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2020] [Revised: 07/15/2020] [Accepted: 07/17/2020] [Indexed: 12/18/2022]
Abstract
Individual cells and cell populations are at the present time investigated with a myriad of analytical tools. While most of them are commercially available, some of these analytical tools are just emerging from research laboratories and are in the developmental phase. Electrochemical sensors which allow the monitoring of low molecular weight compounds released (and / or uptaken) by cells are among these emerging tools. Such sensors are increasingly built using 2D materials (e.g. graphene-based materials, transition metal dichalcogenides, etc.) with the aim of conferring better analytical performances to these devices. The present work critically reviews studies published during the last 10 years describing electrochemical sensors made with 2D materials and exploited to monitor small compounds (e.g. H2O2, ·NO, glucose, etc.) in living biological systems. It also discusses the very few 2D material-based electrochemical sensors which are wearable or usable in vivo. Finally, the present work includes a specific section about 2D material biocompatibility, a fundamental requirement for 2D material-based sensor applications in vitro and in vivo. As such, the review provides a critical view on the state of the art of electrochemical sensors made with 2D materials and used at cellular level and it evaluates the possibility that such sensors will be used on / in the human body on a wider scale.
Collapse
|
32
|
Dong Y, Lin C, Gao S, Manoranjan N, Li W, Fang W, Jin J. Single-layered GO/LDH hybrid nanoporous membranes with improved stability for salt and organic molecules rejection. J Memb Sci 2020. [DOI: 10.1016/j.memsci.2020.118184] [Citation(s) in RCA: 19] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
33
|
Rosenkrans ZT, Sun T, Jiang D, Chen W, Barnhart TE, Zhang Z, Ferreira CA, Wang X, Engle JW, Huang P, Cai W. Selenium-Doped Carbon Quantum Dots Act as Broad-Spectrum Antioxidants for Acute Kidney Injury Management. ADVANCED SCIENCE (WEINHEIM, BADEN-WURTTEMBERG, GERMANY) 2020; 7:2000420. [PMID: 32596126 PMCID: PMC7312409 DOI: 10.1002/advs.202000420] [Citation(s) in RCA: 80] [Impact Index Per Article: 20.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/05/2020] [Revised: 03/06/2020] [Indexed: 05/06/2023]
Abstract
The manifestation of acute kidney injury (AKI) is associated with poor patient outcomes, with treatment options limited to hydration or renal replacement therapies. The onset of AKI is often associated with a surfeit of reactive oxygen species. Here, it is shown that selenium-doped carbon quantum dots (SeCQDs) have broad-spectrum antioxidant properties and prominent renal accumulation in both healthy and AKI mice. Due to these properties, SeCQDs treat or prevent two clinically relevant cases of AKI induced in murine models by either rhabdomyolysis or cisplatin using only 1 or 50 µg per mouse, respectively. The attenuation of AKI in both models is confirmed by blood serum measurements, kidney tissue staining, and relevant biomarkers. The therapeutic efficacy of SeCQDs exceeds amifostine, a drug approved by the Food and Drug Administration that also acts by scavenging free radicals. The findings indicate that SeCQDs show great potential as a treatment option for AKI and possibly other ROS-related diseases.
Collapse
Affiliation(s)
- Zachary T. Rosenkrans
- Department of Pharmaceutical SciencesUniversity of Wisconsin‐MadisonMadisonWI53705USA
| | - Tuanwei Sun
- Marshall Laboratory of Biomedical EngineeringInternational Cancer CenterLaboratory of Evolutionary TheranosticsSchool of Biomedical EngineeringShenzhen University Health Science CenterShenzhen518060China
- Departments of Radiology and Medical PhysicsUniversity of Wisconsin‐MadisonMadisonWI53705USA
| | - Dawei Jiang
- Marshall Laboratory of Biomedical EngineeringInternational Cancer CenterLaboratory of Evolutionary TheranosticsSchool of Biomedical EngineeringShenzhen University Health Science CenterShenzhen518060China
- Departments of Radiology and Medical PhysicsUniversity of Wisconsin‐MadisonMadisonWI53705USA
| | - Weiyu Chen
- Departments of Radiology and Medical PhysicsUniversity of Wisconsin‐MadisonMadisonWI53705USA
| | - Todd E. Barnhart
- Departments of Radiology and Medical PhysicsUniversity of Wisconsin‐MadisonMadisonWI53705USA
| | - Ziyi Zhang
- Department of Materials Science and EngineeringUniversity of Wisconsin‐MadisonMadisonWI53705USA
| | - Carolina A. Ferreira
- Departments of Radiology and Medical PhysicsUniversity of Wisconsin‐MadisonMadisonWI53705USA
| | - Xudong Wang
- Department of Materials Science and EngineeringUniversity of Wisconsin‐MadisonMadisonWI53705USA
| | - Jonathan W. Engle
- Departments of Radiology and Medical PhysicsUniversity of Wisconsin‐MadisonMadisonWI53705USA
| | - Peng Huang
- Marshall Laboratory of Biomedical EngineeringInternational Cancer CenterLaboratory of Evolutionary TheranosticsSchool of Biomedical EngineeringShenzhen University Health Science CenterShenzhen518060China
| | - Weibo Cai
- Department of Pharmaceutical SciencesUniversity of Wisconsin‐MadisonMadisonWI53705USA
- Departments of Radiology and Medical PhysicsUniversity of Wisconsin‐MadisonMadisonWI53705USA
| |
Collapse
|
34
|
Rodrigues AF, Newman L, Jasim D, Mukherjee SP, Wang J, Vacchi IA, Ménard‐Moyon C, Bianco A, Fadeel B, Kostarelos K, Bussy C. Size-Dependent Pulmonary Impact of Thin Graphene Oxide Sheets in Mice: Toward Safe-by-Design. ADVANCED SCIENCE (WEINHEIM, BADEN-WURTTEMBERG, GERMANY) 2020; 7:1903200. [PMID: 32596109 PMCID: PMC7312279 DOI: 10.1002/advs.201903200] [Citation(s) in RCA: 31] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/23/2019] [Revised: 04/07/2020] [Indexed: 05/17/2023]
Abstract
Safety assessment of graphene-based materials (GBMs) including graphene oxide (GO) is essential for their safe use across many sectors of society. In particular, the link between specific material properties and biological effects needs to be further elucidated. Here, the effects of lateral dimensions of GO sheets in acute and chronic pulmonary responses after single intranasal instillation in mice are compared. Micrometer-sized GO induces stronger pulmonary inflammation than nanometer-sized GO, despite reduced translocation to the lungs. Genome-wide RNA sequencing also reveals distinct size-dependent effects of GO, in agreement with the histopathological results. Although large GO, but not the smallest GO, triggers the formation of granulomas that persists for up to 90 days, no pulmonary fibrosis is observed. These latter results can be partly explained by Raman imaging, which evidences the progressive biotransformation of GO into less graphitic structures. The findings demonstrate that lateral dimensions play a fundamental role in the pulmonary response to GO, and suggest that airborne exposure to micrometer-sized GO should be avoided in the production plant or applications, where aerosolized dispersions are likely to occur. These results are important toward the implementation of a safer-by-design approach for GBM products and applications, for the benefit of workers and end-users.
Collapse
Affiliation(s)
- Artur Filipe Rodrigues
- Nanomedicine LabFaculty of Biology, Medicine and HealthUniversity of ManchesterManchester Academic Health Science CentreManchesterM13 9PTUK
- National Graphene InstituteUniversity of ManchesterManchesterM13 9PTUK
- Lydia Becker Institute of Immunology and InflammationSchool of Health SciencesUniversity of ManchesterManchester Academic Health Science CentreManchesterM13 9PTUK
| | - Leon Newman
- Nanomedicine LabFaculty of Biology, Medicine and HealthUniversity of ManchesterManchester Academic Health Science CentreManchesterM13 9PTUK
- National Graphene InstituteUniversity of ManchesterManchesterM13 9PTUK
| | - Dhifaf Jasim
- Nanomedicine LabFaculty of Biology, Medicine and HealthUniversity of ManchesterManchester Academic Health Science CentreManchesterM13 9PTUK
- National Graphene InstituteUniversity of ManchesterManchesterM13 9PTUK
| | - Sourav P. Mukherjee
- Nanosafety & Nanomedicine LaboratoryInstitute of Environmental MedicineKarolinska InstitutetStockholm171 77Sweden
| | - Jun Wang
- Science for Life LaboratoryDepartment of Biochemistry and BiophysicsStockholm UniversityStockholm171 65Sweden
| | - Isabella A. Vacchi
- University of StrasbourgCNRSImmunology, Immunopathology and Therapeutic ChemistryUPR 3572Strasbourg67 084France
| | - Cécilia Ménard‐Moyon
- University of StrasbourgCNRSImmunology, Immunopathology and Therapeutic ChemistryUPR 3572Strasbourg67 084France
| | - Alberto Bianco
- University of StrasbourgCNRSImmunology, Immunopathology and Therapeutic ChemistryUPR 3572Strasbourg67 084France
| | - Bengt Fadeel
- Nanosafety & Nanomedicine LaboratoryInstitute of Environmental MedicineKarolinska InstitutetStockholm171 77Sweden
| | - Kostas Kostarelos
- Nanomedicine LabFaculty of Biology, Medicine and HealthUniversity of ManchesterManchester Academic Health Science CentreManchesterM13 9PTUK
- National Graphene InstituteUniversity of ManchesterManchesterM13 9PTUK
- Catalan Institute of Nanoscience and Nanotechnology (ICN2)Campus UABBellaterraBarcelona08193Spain
| | - Cyrill Bussy
- Nanomedicine LabFaculty of Biology, Medicine and HealthUniversity of ManchesterManchester Academic Health Science CentreManchesterM13 9PTUK
- National Graphene InstituteUniversity of ManchesterManchesterM13 9PTUK
- Lydia Becker Institute of Immunology and InflammationSchool of Health SciencesUniversity of ManchesterManchester Academic Health Science CentreManchesterM13 9PTUK
| |
Collapse
|
35
|
Ma M, Zhu H, Ling J, Gong S, Zhang Y, Xia Y, Tang Z. Quasi-amorphous and Hierarchical Fe 2O 3 Supraparticles: Active T1-Weighted Magnetic Resonance Imaging in Vivo and Renal Clearance. ACS NANO 2020; 14:4036-4044. [PMID: 32196312 DOI: 10.1021/acsnano.9b08570] [Citation(s) in RCA: 33] [Impact Index Per Article: 8.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
The exploration of magnetic resonance imaging (MRI) agents possessing excellent performances and high biosafety is of great importance for both fundamental science research and biomedical applications. In this study, we present that monodisperse Fe2O3 supraparticles (SPs) can act as T1-weighted MRI agents, which not only possess a distinct off-on MRI switch in the tumor microenvironment but also are readily excreted from living bodies due to its quasi-amorphous structure and hierarchical topology design. First, the Fe2O3 SPs have a surface-to-volume ratio obviously smaller than that of their building blocks by means of self-assembly processes, which, on the one hand, causes a rather low r1 relaxivity (0.19 mM-1 s-1) and, on the other hand, can effectively prevent their aggregation after intravenous injection. Second, the Fe2O3 SPs have a dramatic disassembly/degradation-induced active T1-weighted signal readout (more than 6 times the r1 value enhancement and about 20 times the r2/r1 ratio decrease) in the tumor microenvironment, resulting in a high signal-to-noise ratio for imaging performances. Therefore, they possess excellent in vivo imaging capacity, even with a tumor size as small as 5 mm3. Third, the disassembled/decomposed behaviors of the Fe2O3 SPs facilitate their timely clearance/excretion from living bodies. In particular, they exhibit distinct renal clearance behavior without any kidney damage with the right dosage. Fourth, the favorable biodegradability of the as-prepared Fe2O3 SPs can further relieve the concerns about the unclear biological effects, particularly on nanomaterials, in general.
Collapse
Affiliation(s)
- Mingrou Ma
- Key Laboratory of Functional Molecular Solids, Ministry of Education, College of Chemistry and Materials Science, Anhui Normal University, Wuhu 241000, China
| | - Hui Zhu
- Key Laboratory of Functional Molecular Solids, Ministry of Education, College of Chemistry and Materials Science, Anhui Normal University, Wuhu 241000, China
| | - Jing Ling
- Key Laboratory of Functional Molecular Solids, Ministry of Education, College of Chemistry and Materials Science, Anhui Normal University, Wuhu 241000, China
| | - Suqin Gong
- Key Laboratory of Functional Molecular Solids, Ministry of Education, College of Chemistry and Materials Science, Anhui Normal University, Wuhu 241000, China
| | - Yin Zhang
- CAS Key Laboratory of Nanosystem and Hierarchical Fabrication, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China
| | - Yunsheng Xia
- Key Laboratory of Functional Molecular Solids, Ministry of Education, College of Chemistry and Materials Science, Anhui Normal University, Wuhu 241000, China
| | - Zhiyong Tang
- CAS Key Laboratory of Nanosystem and Hierarchical Fabrication, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China
| |
Collapse
|
36
|
Tan E, Li BL, Ariga K, Lim CT, Garaj S, Leong DT. Toxicity of Two-Dimensional Layered Materials and Their Heterostructures. Bioconjug Chem 2019; 30:2287-2299. [PMID: 31381854 DOI: 10.1021/acs.bioconjchem.9b00502] [Citation(s) in RCA: 29] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
Two-dimensional layered materials (2D LMs) are taking the scientific world by storm. Graphene epitomizes 2D LMs with many interesting properties and corresponding applications. Following the footsteps of graphene, many other types of 2D LMs such as transition metal dichalcogenides, black phosphorus, and graphitic-phase C3N4 nanosheets are emerging to be equally interesting as graphene and its derivatives. Some of these applications such as nanomedicine do have a high probability of human exposure. This review focuses on the biological and toxicity effects of 2D LMs and their associated mechanisms linking their chemistries to their biological end points. This review aims to help researchers to predict and mitigate any toxic effects. With understanding, redesign of newer and safer 2D LMs becomes possible.
Collapse
Affiliation(s)
- Eveline Tan
- Department of Chemical & Biomolecular Engineering , National University of Singapore , Singapore 117585 , Singapore
| | - Bang Lin Li
- Department of Chemical & Biomolecular Engineering , National University of Singapore , Singapore 117585 , Singapore.,School of Chemistry and Chemical Engineering , Southwest University , Chongqing 400715 , P. R. China
| | - Katsuhiko Ariga
- WPI-MANA , National Institute for Materials Science (NIMS) , 1-1 Namiki , Tsukuba , Ibaraki 305-0044 , Japan.,Department of Advanced Materials Science, Graduate School of Frontier Sciences , The University of Tokyo , 5-1-5 Kashiwanoha , Kashiwa , Chiba 277-8561 , Japan
| | - Chwee-Teck Lim
- Department of Physics , National University of Singapore , Singapore 117542 , Singapore.,Department of Biomedical Engineering , National University of Singapore , Singapore 117575 , Singapore.,Centre for Advanced 2D Materials , Graphene Research Centre , Singapore 117546 , Singapore.,NUS Graduate School for Integrative Sciences and Engineering , National University of Singapore , Singapore 117456 , Singapore.,Mechanobiology Institute , National University of Singapore , Singapore 117411 , Singapore
| | - Slaven Garaj
- Department of Physics , National University of Singapore , Singapore 117542 , Singapore.,Department of Biomedical Engineering , National University of Singapore , Singapore 117575 , Singapore.,Centre for Advanced 2D Materials , Graphene Research Centre , Singapore 117546 , Singapore
| | - David Tai Leong
- Department of Chemical & Biomolecular Engineering , National University of Singapore , Singapore 117585 , Singapore.,NUS Graduate School for Integrative Sciences and Engineering , National University of Singapore , Singapore 117456 , Singapore
| |
Collapse
|
37
|
Castilla-Cortázar I, Vidaurre A, Marí B, Campillo-Fernández AJ. Morphology, Crystallinity, and Molecular Weight of Poly(ε-caprolactone)/Graphene Oxide Hybrids. Polymers (Basel) 2019; 11:polym11071099. [PMID: 31261770 PMCID: PMC6680561 DOI: 10.3390/polym11071099] [Citation(s) in RCA: 31] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2019] [Revised: 06/18/2019] [Accepted: 06/21/2019] [Indexed: 11/18/2022] Open
Abstract
A study was carried out to determine the effects of graphene oxide (GO) filler on the properties of poly(ε-caprolactone) (PCL) films. A series of nanocomposites were prepared, incorporating different graphene oxide filler contents (0.1, 0.2, and 0.5 wt%) by the solution mixing method, and an in-depth study was made of the morphological changes, crystallization, infrared absorbance, molecular weight, thermal properties, and biocompatibility as a function of GO content to determine their suitability for use in biomedical applications. The infrared absorbance showed the existence of intermolecular hydrogen bonds between the PCL’s carbonyl groups and the GO’s hydrogen-donating groups, which is in line with the apparent reduction in molecular weight at higher GO contents, indicated by the results of the gel permeation chromatography (GPC), and the thermal property analysis. Polarized optical microscopy (POM) showed that GO acts as a nucleating point for PCL crystals, increasing crystallinity and crystallization temperature. The biological properties of the composites studied indicate that adding only 0.1 wt% of GO can improve cellular viability and that the composite shows promise for use in biomedical applications.
Collapse
Affiliation(s)
- Isabel Castilla-Cortázar
- Centro de Biomateriales e Ingeniería Tisular, Universitat Politècnica de València, 46022 Valencia, Spain.
| | - Ana Vidaurre
- Centro de Biomateriales e Ingeniería Tisular, Universitat Politècnica de València, 46022 Valencia, Spain.
- CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Valencia, Spain.
| | - Bernabé Marí
- Departamento de Física Aplicada-IDF, Universitat Politècnica de València, 46022 Valencia, Spain.
| | | |
Collapse
|
38
|
Naumenko V, Nikitin A, Kapitanova K, Melnikov P, Vodopyanov S, Garanina A, Valikhov M, Ilyasov A, Vishnevskiy D, Markov A, Golyshev S, Zhukov D, Alieva I, Abakumov M, Chekhonin V, Majouga A. Intravital microscopy reveals a novel mechanism of nanoparticles excretion in kidney. J Control Release 2019; 307:368-378. [PMID: 31247280 DOI: 10.1016/j.jconrel.2019.06.026] [Citation(s) in RCA: 22] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2019] [Revised: 06/18/2019] [Accepted: 06/21/2019] [Indexed: 11/18/2022]
Abstract
Developing nanocarriers that accumulate in targeted organs and are harmlessly eliminated still remains a big challenge. Nanoparticles (NP) biodistribution is governed by their size, composition, surface charge and coverage. The current thinking in bionanotechnology is that renal clearance is limited by glomerular basement membrane pore size (≈6 nm), although there is a growing evidence that NP exceeding the threshold can also be excreted with urine. Here we compare biodistribution of PEGylated 140 nm iron oxide cubes and clusters with a special focus on renal accumulation and excretion. Atomic emission spectroscopy, fluorescent microscopy and magnetic resonance imaging revealed rapid and transient accumulation of magnetic NP in kidney. Using intravital microscopy we tracked in real time NP translocation from peritubular capillaries to basal compartment of tubular cells and subsequent excretion to the lumen within 60 min after systemic administration. Transmission electron microscopy revealed persistence of intact full-sized NP in urine 2 h post injection. The results suggest that translocation through peritubular endothelium to tubular epithelial cells is an alternative mechanism of renal clearance enabling excretion of NP above glomerular cut-off size.
Collapse
Affiliation(s)
- Victor Naumenko
- National University of Science and Technology (MISIS), Moscow 119049, Russia.
| | - Aleksey Nikitin
- National University of Science and Technology (MISIS), Moscow 119049, Russia; M.V. Lomonosov Moscow State University, Moscow 119991, Russia
| | | | - Pavel Melnikov
- Department of Medical Nanobiotechnology, N.I Pirogov Russian National Research Medical University, Moscow 117997, Russia
| | - Stepan Vodopyanov
- National University of Science and Technology (MISIS), Moscow 119049, Russia
| | - Anastasiia Garanina
- National University of Science and Technology (MISIS), Moscow 119049, Russia
| | - Marat Valikhov
- Department of Medical Nanobiotechnology, N.I Pirogov Russian National Research Medical University, Moscow 117997, Russia
| | - Artem Ilyasov
- National University of Science and Technology (MISIS), Moscow 119049, Russia
| | - Daniil Vishnevskiy
- Department of Medical Nanobiotechnology, N.I Pirogov Russian National Research Medical University, Moscow 117997, Russia
| | - Aleksey Markov
- M.V. Lomonosov Moscow State University, Moscow 119991, Russia
| | - Sergei Golyshev
- M.V. Lomonosov Moscow State University, Moscow 119991, Russia
| | - Dmitry Zhukov
- National University of Science and Technology (MISIS), Moscow 119049, Russia
| | - Irina Alieva
- A.N Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 119991 Moscow, Russia
| | - Maxim Abakumov
- National University of Science and Technology (MISIS), Moscow 119049, Russia; Department of Medical Nanobiotechnology, N.I Pirogov Russian National Research Medical University, Moscow 117997, Russia
| | - Vladimir Chekhonin
- Department of Medical Nanobiotechnology, N.I Pirogov Russian National Research Medical University, Moscow 117997, Russia
| | - Alexander Majouga
- National University of Science and Technology (MISIS), Moscow 119049, Russia; D. Mendeleev University of Chemical Technology of Russia, Moscow 125047, Russia
| |
Collapse
|
39
|
Martín C, Kostarelos K, Prato M, Bianco A. Biocompatibility and biodegradability of 2D materials: graphene and beyond. Chem Commun (Camb) 2019; 55:5540-5546. [PMID: 31033990 DOI: 10.1039/c9cc01205b] [Citation(s) in RCA: 118] [Impact Index Per Article: 23.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
The potential risks associated with two-dimensional (2D) nanomaterials may cause serious concerns about their real applications and impact in biological systems. In addition, the demonstration of biodegradability of these flat nanomaterials is essential in living organisms. Here, we summarise the state-of-the-art in the field of biocompatibility and biodegradability of graphene-related materials (such as 2D materials like MoS2, BN or WS2). The impact of chemical functionalisation on the potential control of the biodegradability profile of these structures is also discussed.
Collapse
Affiliation(s)
- Cristina Martín
- University of Strasbourg, CNRS, Immunology, Immunopathology and Therapeutic Chemistry, 67000 Strasbourg, France.
| | | | | | | |
Collapse
|
40
|
Guilbaud-Chéreau C, Dinesh B, Schurhammer R, Collin D, Bianco A, Ménard-Moyon C. Protected Amino Acid-Based Hydrogels Incorporating Carbon Nanomaterials for Near-Infrared Irradiation-Triggered Drug Release. ACS APPLIED MATERIALS & INTERFACES 2019; 11:13147-13157. [PMID: 30865420 DOI: 10.1021/acsami.9b02482] [Citation(s) in RCA: 22] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
Molecular gels formed by the self-assembly of low-molecular-weight gelators have received increasing interest because of their potential applications in drug delivery. In particular, the ability of peptides and amino acids to spontaneously self-assemble into three-dimensional fibrous network has been exploited in the development of hydrogels. In this context, we have investigated the capacity of binary mixtures of aromatic amino acid derivatives to form hydrogels. Carbon nanomaterials, namely oxidized carbon nanotubes or graphene oxide, were incorporated in the two most stable hydrogels, formed by Fmoc-Tyr-OH/Fmoc-Tyr(Bzl)-OH and Fmoc-Phe-OH/Fmoc-Tyr(Bzl)-OH, respectively. The structural and physical properties of these gels were assessed using microscopic techniques and rheology. Circular dichroism and molecular dynamics simulations demonstrated that the hydrogel formation was mainly driven by aromatic interactions. Finally, a model hydrophilic drug (l-ascorbic acid) was loaded into the hybrid hydrogels at a high concentration. Under near-infrared light irradiation, a high amount of drug was released triggered by the heat generated by the carbon nanomaterials, thus offering interesting perspectives for controlled drug delivery.
Collapse
Affiliation(s)
- Chloé Guilbaud-Chéreau
- University of Strasbourg, CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR 3572 , 67000 Strasbourg , France
| | - Bhimareddy Dinesh
- University of Strasbourg, CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR 3572 , 67000 Strasbourg , France
| | - Rachel Schurhammer
- Laboratoire de Chimie Moléculaire de l'état Solide (UMR 7140 CNRS), Université de Strasbourg , 1 rue Blaise Pascal , 67081 Strasbourg , France
| | - Dominique Collin
- Institut Charles Sadron , Université de Strasbourg , 23 rue du Loess, BP 84047 , 67034 Strasbourg Cedex , France
| | - Alberto Bianco
- University of Strasbourg, CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR 3572 , 67000 Strasbourg , France
| | - Cécilia Ménard-Moyon
- University of Strasbourg, CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR 3572 , 67000 Strasbourg , France
| |
Collapse
|
41
|
Pradeep A, Satya Prasad S, Suryam L, Prasanna Kumari P. A review on 2D materials for bio-applications. ACTA ACUST UNITED AC 2019. [DOI: 10.1016/j.matpr.2019.07.617] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
|
42
|
Fadeel B, Bussy C, Merino S, Vázquez E, Flahaut E, Mouchet F, Evariste L, Gauthier L, Koivisto AJ, Vogel U, Martín C, Delogu LG, Buerki-Thurnherr T, Wick P, Beloin-Saint-Pierre D, Hischier R, Pelin M, Candotto Carniel F, Tretiach M, Cesca F, Benfenati F, Scaini D, Ballerini L, Kostarelos K, Prato M, Bianco A. Safety Assessment of Graphene-Based Materials: Focus on Human Health and the Environment. ACS NANO 2018; 12:10582-10620. [PMID: 30387986 DOI: 10.1021/acsnano.8b04758] [Citation(s) in RCA: 302] [Impact Index Per Article: 50.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/20/2023]
Abstract
Graphene and its derivatives are heralded as "miracle" materials with manifold applications in different sectors of society from electronics to energy storage to medicine. The increasing exploitation of graphene-based materials (GBMs) necessitates a comprehensive evaluation of the potential impact of these materials on human health and the environment. Here, we discuss synthesis and characterization of GBMs as well as human and environmental hazard assessment of GBMs using in vitro and in vivo model systems with the aim to understand the properties that underlie the biological effects of these materials; not all GBMs are alike, and it is essential that we disentangle the structure-activity relationships for this class of materials.
Collapse
Affiliation(s)
- Bengt Fadeel
- Nanosafety & Nanomedicine Laboratory, Institute of Environmental Medicine , Karolinska Institutet , 17777 Stockholm , Sweden
| | - Cyrill Bussy
- Nanomedicine Laboratory, Faculty of Biology, Medicine & Health , University of Manchester , Manchester M13 9PL , United Kingdom
| | - Sonia Merino
- Faculty of Chemical Science and Technology , University of Castilla-La Mancha , 13071 Ciudad Real , Spain
| | - Ester Vázquez
- Faculty of Chemical Science and Technology , University of Castilla-La Mancha , 13071 Ciudad Real , Spain
| | | | | | | | - Laury Gauthier
- CNRS, Université Paul Sabatier , 31062 Toulouse , France
| | - Antti J Koivisto
- National Research Centre for the Working Environment , 2100 Copenhagen , Denmark
| | - Ulla Vogel
- National Research Centre for the Working Environment , 2100 Copenhagen , Denmark
| | - Cristina Martín
- University of Strasbourg, CNRS , Immunology, Immunopathology and Therapeutic Chemistry , 67000 Strasbourg , France
| | - Lucia G Delogu
- Department of Chemistry and Pharmacy University of Sassari , Sassari 7100 , Italy
- Istituto di Ricerca Pediatrica , Fondazione Città della Speranza , 35129 Padova , Italy
| | - Tina Buerki-Thurnherr
- Swiss Federal Laboratories for Materials Science and Technology (EMPA) , 9014 St. Gallen , Switzerland
| | - Peter Wick
- Swiss Federal Laboratories for Materials Science and Technology (EMPA) , 9014 St. Gallen , Switzerland
| | | | - Roland Hischier
- Swiss Federal Laboratories for Materials Science and Technology (EMPA) , 9014 St. Gallen , Switzerland
| | - Marco Pelin
- Department of Life Sciences , University of Trieste , 34127 Trieste , Italy
| | | | - Mauro Tretiach
- Department of Life Sciences , University of Trieste , 34127 Trieste , Italy
| | - Fabrizia Cesca
- Center for Synaptic Neuroscience and Technology , Istituto Italiano di Tecnologia , 16132 Genova , Italy
| | - Fabio Benfenati
- Center for Synaptic Neuroscience and Technology , Istituto Italiano di Tecnologia , 16132 Genova , Italy
| | - Denis Scaini
- Scuola Internazionale Superiore di Studi Avanzati (SISSA) , 34136 Trieste , Italy
| | - Laura Ballerini
- Scuola Internazionale Superiore di Studi Avanzati (SISSA) , 34136 Trieste , Italy
| | - Kostas Kostarelos
- Nanomedicine Laboratory, Faculty of Biology, Medicine & Health , University of Manchester , Manchester M13 9PL , United Kingdom
| | - Maurizio Prato
- Department of Chemical and Pharmaceutical Sciences , University of Trieste , 34127 Trieste , Italy
- Carbon Nanobiotechnology Laboratory , CIC BiomaGUNE , 20009 San Sebastian , Spain
- Basque Foundation for Science, Ikerbasque , 48013 Bilbao , Spain
| | - Alberto Bianco
- University of Strasbourg, CNRS , Immunology, Immunopathology and Therapeutic Chemistry , 67000 Strasbourg , France
| |
Collapse
|
43
|
Immunological impact of graphene oxide sheets in the abdominal cavity is governed by surface reactivity. Arch Toxicol 2018; 92:3359-3379. [PMID: 30259072 PMCID: PMC6208965 DOI: 10.1007/s00204-018-2303-z] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2018] [Accepted: 09/13/2018] [Indexed: 11/12/2022]
Abstract
Graphene oxide (GO) is an oxidised form of graphene that has attracted commercial interest in multiple applications, including inks, printed electronics and spray coatings, which all raise health concerns due to potential creation of inhalable aerosols. Although a number of studies have discussed the toxicity of GO sheets, the in vivo impact of their lateral dimensions is still not clear. Here, we compared the effects of large GO sheets (l-GO, 1–20 µm) with those of small GO sheets (s-GO, < 1 µm) in terms of mesothelial damage and peritoneal inflammation, after intraperitoneal (i.p.) injection in mice. To benchmark the outcomes, long and rigid multi-walled carbon nanotubes (MWCNTs) that were shown to be associated with asbestos-like pathogenicity on the mesothelium were also tested. Our aim was to assess whether lateral dimensions can be a predictor of inflammogenicity for GO sheets in a similar fashion as length is for MWCNTs. While long MWCNTs dispersed in 0.5% BSA induced a granulomatous response on the diaphragmatic mesothelium and immune cell recruitment to the peritoneal cavity, GO sheets dispersed under similar conditions did not cause any response, regardless of their lateral dimensions. We further interrogated whether tuning the surface reactivity of GO by testing different dispersions (5% dextrose instead of 0.5% BSA) may change the biological outcome. Although the change of dispersion did not alter the impact of GO on the mesothelium (i.e. no granuloma), we observed that, when dispersed in protein-free 5% dextrose solution, s-GO elicited a greater recruitment of monocytic cells to the peritoneal cavity than l-GO, or when dispersed in protein-containing solution. Such recruitment coincided with the greater ability of s-GO to interact in vivo with peritoneal macrophages and was associated with a greater surface reactivity in comparison to l-GO. In conclusion, large dimension was not a determining factor of the immunological impact of GO sheets after i.p. administration. For an equal dose, GO sheets with lateral dimensions similar to the length of long MWCNTs were less pathogenic than the MWCNTs. On the other hand, surface reactivity and the ability of some smaller GO sheets to interact more readily with immune cells seem to be key parameters that can be tuned to improve the safety profile of GO. In particular, the choice of dispersion modality, which affected these two parameters, was found to be of crucial importance in the assessment of GO impact in this model. Overall, these findings are essential for a better understanding of the parameters governing GO toxicity and inflammation, and the rational design of safe GO-based formulations for various applications, including biomedicine.
Collapse
|
44
|
Nanotechnological foundations of a «new» Nephrology. Nefrologia 2018; 38:368-378. [PMID: 29778557 DOI: 10.1016/j.nefro.2018.02.007] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2018] [Accepted: 02/12/2018] [Indexed: 11/24/2022] Open
Abstract
After contextualising the generic frameworks of nanotechnology and nanomedicine, the 2disciplines are discussed in the field of Nephrology. The potential downside to nanonephrology is the renal clearance of nanoparticles, the use of which is ever-increasing both for nanomedicinal purposes and in nanofoods. The positive impact of nanotechnology in Nephrology is centred on the development of renal nanodiagnostics for basic renal function studies, the early diagnosis of acute kidney injury, reliable and simple follow-up of chronic kidney disease and the improvement of magnetic resonance imaging. Renal drug nanotherapies comprise an important and dual-faceted area: The protection of drugs and nephrotoxic agents (e.g. antibiotics, antiretrovirals, contrast media, etc.) on the one hand, and the development of new kidney disease medications on the other. Renal 'nanotheranostics' is a promising but little-studied area. The impact of nanostructured supports on renal tissue regeneration is also discussed. The article concludes with a brief analysis of the various nanonephrology perspectives.
Collapse
|
45
|
Li R, Guiney LM, Chang CH, Mansukhani ND, Ji Z, Wang X, Liao YP, Jiang W, Sun B, Hersam MC, Nel AE, Xia T. Surface Oxidation of Graphene Oxide Determines Membrane Damage, Lipid Peroxidation, and Cytotoxicity in Macrophages in a Pulmonary Toxicity Model. ACS NANO 2018; 12:1390-1402. [PMID: 29328670 PMCID: PMC5834379 DOI: 10.1021/acsnano.7b07737] [Citation(s) in RCA: 160] [Impact Index Per Article: 26.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/20/2023]
Abstract
While two-dimensional graphene oxide (GO) is used increasingly in biomedical applications, there is uncertainty on how specific physicochemical properties relate to biocompatibility in mammalian systems. Although properties such as lateral size and the colloidal properties of the nanosheets are important, the specific material properties that we address here is the oxidation state and reactive surface groups on the planar surface. In this study, we used a GO library, comprising pristine, reduced (rGO), and hydrated GO (hGO), in which quantitative assessment of the hydroxyl, carboxyl, epoxy, and carbon radical contents was used to study the impact on epithelial cells and macrophages, as well as in the murine lung. Strikingly, we observed that hGO, which exhibits the highest carbon radical density, was responsible for the generation of cell death in THP-1 and BEAS-2B cells as a consequence of lipid peroxidation of the surface membrane, membrane lysis, and cell death. In contrast, pristine GO had lesser effects, while rGO showed extensive cellular uptake with minimal effects on viability. In order to see how these in vitro effects relate to adverse outcomes in the lung, mice were exposed to GOs by oropharyngeal aspiration. Animal sacrifice after 40 h demonstrated that hGO was more prone than other materials to generate acute lung inflammation, accompanied by the highest lipid peroxidation in alveolar macrophages, cytokine production (LIX, MCP-1), and LDH release in bronchoalveolar lavage fluid. Pristine GO showed less toxicity, whereas rGO had minimal effects. We demonstrate that the surface oxidation state and carbon radical content play major roles in the induction of toxicity by GO in mammalian cells and the lung.
Collapse
Affiliation(s)
- Ruibin Li
- School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou, 215123, China
| | - Linda M. Guiney
- Departments of Materials Science and Engineering, Chemistry, and Medicine, Northwestern University, Evanston, Illinois 60208, United States
| | - Chong Hyun Chang
- California NanoSystems Institute, University of California, University of California, Los Angeles, California 90095, United States
| | - Nikhita D. Mansukhani
- Departments of Materials Science and Engineering, Chemistry, and Medicine, Northwestern University, Evanston, Illinois 60208, United States
| | - Zhaoxia Ji
- California NanoSystems Institute, University of California, University of California, Los Angeles, California 90095, United States
| | - Xiang Wang
- California NanoSystems Institute, University of California, University of California, Los Angeles, California 90095, United States
| | - Yu-Pei Liao
- Division of NanoMedicine, Department of Medicine, University of California, University of California, Los Angeles, California 90095, United States
| | | | - Bingbing Sun
- Division of NanoMedicine, Department of Medicine, University of California, University of California, Los Angeles, California 90095, United States
| | - Mark C. Hersam
- Departments of Materials Science and Engineering, Chemistry, and Medicine, Northwestern University, Evanston, Illinois 60208, United States
| | - Andre E. Nel
- Division of NanoMedicine, Department of Medicine, University of California, University of California, Los Angeles, California 90095, United States
- Center for Environmental Implications of Nanotechnology, University of California, University of California, Los Angeles, California 90095, United States
- California NanoSystems Institute, University of California, University of California, Los Angeles, California 90095, United States
- Corresponding Author: Tian Xia, Ph.D.; and Andre Nel, Ph.D., Department of Medicine, Division of NanoMedicine, UCLA School of Medicine, 52-175, CHS, 10833 Le Conte Ave, Los Angeles, CA 90095-1680. Tel: (310) 983-3359, Fax: (310) 206-8107, ,
| | - Tian Xia
- Division of NanoMedicine, Department of Medicine, University of California, University of California, Los Angeles, California 90095, United States
- Center for Environmental Implications of Nanotechnology, University of California, University of California, Los Angeles, California 90095, United States
- California NanoSystems Institute, University of California, University of California, Los Angeles, California 90095, United States
- Corresponding Author: Tian Xia, Ph.D.; and Andre Nel, Ph.D., Department of Medicine, Division of NanoMedicine, UCLA School of Medicine, 52-175, CHS, 10833 Le Conte Ave, Los Angeles, CA 90095-1680. Tel: (310) 983-3359, Fax: (310) 206-8107, ,
| |
Collapse
|
46
|
Vranic S, Rodrigues AF, Buggio M, Newman L, White MRH, Spiller DG, Bussy C, Kostarelos K. Live Imaging of Label-Free Graphene Oxide Reveals Critical Factors Causing Oxidative-Stress-Mediated Cellular Responses. ACS NANO 2018; 12:1373-1389. [PMID: 29286639 DOI: 10.1021/acsnano.7b07734] [Citation(s) in RCA: 63] [Impact Index Per Article: 10.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/20/2023]
Abstract
The interest in graphene and its translation into commercial products has been expanding at a high pace. Based on previously described pulmonary safety concerns for carbon nanomaterials, there is a great need to define parameters guiding interactions between graphene-based materials and the pulmonary system. The aim of the present study was to determine the importance of two critical parameters: lateral dimensions of the material and coating with proteins in relation to each other and their pulmonary impact. Endotoxin-free materials with distinct lateral dimensions, s-GO (50-200 nm) and l-GO (5-15 μm), were produced and thoroughly characterized. Exploiting intrinsic fluorescence of graphene oxide (GO) and using confocal live-cell imaging, the behavior of the cells in response to the material was visualized in real time. Although BEAS-2B cells internalized GO efficiently, l-GO was linked to higher plasma membrane interactions correlated with elevated reactive oxygen species (ROS) levels, pro-inflammatory response, and greater cytotoxicity, in agreement with the oxidative stress paradigm. For both GO types, the presence of serum alleviated lipid peroxidation of plasma membrane and decreased intracellular ROS levels. However, protein coating was not enough to entirely mitigate toxicity and inflammatory response induced by l-GO. In vitro results were validated in vivo, as l-GO was more prone to induce pulmonary granulomatous response in mice compared to s-GO. In conclusion, the lateral dimension of GO played a more important role than serum protein coating in determining biological responses to the material. It was also demonstrated that time-lapse imaging of live cells interacting with label-free GO sheets can be used as a tool to assess GO-induced cytotoxicity.
Collapse
Affiliation(s)
- Sandra Vranic
- Nanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester , AV Hill Building, Manchester M13 9PT, U.K
- National Graphene Institute, The University of Manchester , Booth Street East, Manchester M13 9PL, U.K
| | - Artur Filipe Rodrigues
- Nanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester , AV Hill Building, Manchester M13 9PT, U.K
- National Graphene Institute, The University of Manchester , Booth Street East, Manchester M13 9PL, U.K
| | - Maurizio Buggio
- Nanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester , AV Hill Building, Manchester M13 9PT, U.K
- National Graphene Institute, The University of Manchester , Booth Street East, Manchester M13 9PL, U.K
| | - Leon Newman
- Nanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester , AV Hill Building, Manchester M13 9PT, U.K
- National Graphene Institute, The University of Manchester , Booth Street East, Manchester M13 9PL, U.K
| | - Michael R H White
- School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester , Michael Smith Building, Manchester M13 9PT, U.K
| | - David G Spiller
- FBMH Platform Sciences, Enabling Technologies & Infrastructure, FBMH Research & Innovation, Faculty of Biology, Medicine and Health, The University of Manchester , Michael Smith Building, Manchester M13 9PT, U.K
| | - Cyrill Bussy
- Nanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester , AV Hill Building, Manchester M13 9PT, U.K
- National Graphene Institute, The University of Manchester , Booth Street East, Manchester M13 9PL, U.K
| | - Kostas Kostarelos
- Nanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester , AV Hill Building, Manchester M13 9PT, U.K
- National Graphene Institute, The University of Manchester , Booth Street East, Manchester M13 9PL, U.K
| |
Collapse
|
47
|
Xu J, Yu M, Carter P, Hernandez E, Dang A, Kapur P, Hsieh JT, Zheng J. In Vivo X-ray Imaging of Transport of Renal Clearable Gold Nanoparticles in the Kidneys. Angew Chem Int Ed Engl 2017; 56:13356-13360. [PMID: 28881491 PMCID: PMC5909191 DOI: 10.1002/anie.201707819] [Citation(s) in RCA: 59] [Impact Index Per Article: 8.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2017] [Indexed: 12/12/2022]
Abstract
With more and more engineered nanoparticles (NPs) being designed renal clearable for clinical translation, fundamental understanding of their transport in the different compartments of kidneys becomes increasingly important. Here, we report noninvasive X-ray imaging of renal clearable gold NPs (AuNPs) in normal and nephropathic kidneys. By quantifying the transport kinetics of the AuNPs in cortex, medulla and pelvis of the normal and injured kidneys, we found that ureteral obstruction not just blocked the NP elimination through the ureter but also slowed down their transport from the medulla to pelvis and enhanced the cellular uptake. Moreover, the transport kinetics of the NPs and renal anatomic details can be precisely correlated with local pathological lesion. These findings not only advance our understandings of the nano-bio interactions in kidneys but also offer a new pathway to noninvasively image kidney dysfunction and local injuries at the anatomical level.
Collapse
Affiliation(s)
- Jing Xu
- Department of Chemistry and Biochemistry, The University of Texas at Dallas, 800 W. Campbell Rd., Richardson, TX, 75080, USA
| | - Mengxiao Yu
- Department of Chemistry and Biochemistry, The University of Texas at Dallas, 800 W. Campbell Rd., Richardson, TX, 75080, USA
| | - Phoebe Carter
- Department of Chemistry and Biochemistry, The University of Texas at Dallas, 800 W. Campbell Rd., Richardson, TX, 75080, USA
| | - Elizabeth Hernandez
- Department of Urology, The University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX, 75390, USA
| | - Andrew Dang
- Department of Urology, The University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX, 75390, USA
| | - Payal Kapur
- Department of Urology, The University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX, 75390, USA
- Department of Pathology, The University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX, 75390, USA
| | - Jer-Tsong Hsieh
- Department of Urology, The University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX, 75390, USA
| | - Jie Zheng
- Department of Chemistry and Biochemistry, The University of Texas at Dallas, 800 W. Campbell Rd., Richardson, TX, 75080, USA
- Department of Urology, The University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX, 75390, USA
| |
Collapse
|
48
|
Xu J, Yu M, Carter P, Hernandez E, Dang A, Kapur P, Hsieh JT, Zheng J. In Vivo X-ray Imaging of Transport of Renal Clearable Gold Nanoparticles in the Kidneys. Angew Chem Int Ed Engl 2017. [DOI: 10.1002/ange.201707819] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Affiliation(s)
- Jing Xu
- Department of Chemistry and Biochemistry; The University of Texas at Dallas; 800 W. Campbell Rd. Richardson TX 75080 USA
| | - Mengxiao Yu
- Department of Chemistry and Biochemistry; The University of Texas at Dallas; 800 W. Campbell Rd. Richardson TX 75080 USA
| | - Phoebe Carter
- Department of Chemistry and Biochemistry; The University of Texas at Dallas; 800 W. Campbell Rd. Richardson TX 75080 USA
| | - Elizabeth Hernandez
- Department of Urology; The University of Texas Southwestern Medical Center; 5323 Harry Hines Blvd. Dallas TX 75390 USA
| | - Andrew Dang
- Department of Urology; The University of Texas Southwestern Medical Center; 5323 Harry Hines Blvd. Dallas TX 75390 USA
| | - Payal Kapur
- Department of Urology; The University of Texas Southwestern Medical Center; 5323 Harry Hines Blvd. Dallas TX 75390 USA
- Department of Pathology; The University of Texas Southwestern Medical Center; 5323 Harry Hines Blvd. Dallas TX 75390 USA
| | - Jer-Tsong Hsieh
- Department of Urology; The University of Texas Southwestern Medical Center; 5323 Harry Hines Blvd. Dallas TX 75390 USA
| | - Jie Zheng
- Department of Chemistry and Biochemistry; The University of Texas at Dallas; 800 W. Campbell Rd. Richardson TX 75080 USA
- Department of Urology; The University of Texas Southwestern Medical Center; 5323 Harry Hines Blvd. Dallas TX 75390 USA
| |
Collapse
|
49
|
Fahmi T, Branch LD, Nima ZA, Jang DS, Savenka AV, Biris AS, Basnakian AG. Mechanism of graphene-induced cytotoxicity: Role of endonucleases. J Appl Toxicol 2017; 37:1325-1332. [DOI: 10.1002/jat.3462] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2017] [Revised: 02/04/2017] [Accepted: 02/05/2017] [Indexed: 01/09/2023]
Affiliation(s)
- Tariq Fahmi
- Department of Pharmacology and Toxicology; University of Arkansas for Medical Science; Little Rock AR USA
| | - La Donna Branch
- Department of Pharmacology and Toxicology; University of Arkansas for Medical Science; Little Rock AR USA
| | - Zeid A. Nima
- Center for Integrative Nanotechnology Sciences; University of Arkansas at Little Rock; Little Rock AR USA
| | - Dae Song Jang
- Department of Pharmacology and Toxicology; University of Arkansas for Medical Science; Little Rock AR USA
| | - Alena V. Savenka
- Department of Pharmacology and Toxicology; University of Arkansas for Medical Science; Little Rock AR USA
| | - Alexandru S. Biris
- Center for Integrative Nanotechnology Sciences; University of Arkansas at Little Rock; Little Rock AR USA
| | - Alexei G. Basnakian
- Department of Pharmacology and Toxicology; University of Arkansas for Medical Science; Little Rock AR USA
- Central Arkansas Veterans Healthcare System; Little Rock AR USA
| |
Collapse
|
50
|
Chen P, Yan LT. Physical principles of graphene cellular interactions: computational and theoretical accounts. J Mater Chem B 2017; 5:4290-4306. [DOI: 10.1039/c6tb03310e] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
Abstract
Clarifying the physical principles of graphene cellular interactions is critical for the wider application of graphene-based nanomaterials in nanomedicine. This review highlights the advances in computational and theoretical accounts for this emerging field.
Collapse
Affiliation(s)
- Pengyu Chen
- Key Laboratory of Advanced Materials (MOE)
- Department of Chemical Engineering
- Tsinghua University
- Beijing 100084
- P. R. China
| | - Li-Tang Yan
- Key Laboratory of Advanced Materials (MOE)
- Department of Chemical Engineering
- Tsinghua University
- Beijing 100084
- P. R. China
| |
Collapse
|